Home New advances in protein engineering for industrial applications: Key takeaways
Article Open Access

New advances in protein engineering for industrial applications: Key takeaways

  • Giles Obinna Ndochinwa EMAIL logo , Qing-Yan Wang , Nkwachukwu Oziamara Okoro , Oyetugo Chioma Amadi , Tochukwu Nwamaka Nwagu , Chukwudi Innocent Nnamchi , Anene Nwabu Moneke and Arome Solomon Odiba EMAIL logo
Published/Copyright: June 17, 2024
Download Article (PDF)
Open Life Sciences
From the journal Open Life Sciences Volume 19 Issue 1

Abstract

Recent advancements in protein/enzyme engineering have enabled the production of a diverse array of high-value compounds in microbial systems with the potential for industrial applications. The goal of this review is to articulate some of the most recent protein engineering advances in bacteria, yeast, and other microbial systems to produce valuable substances. These high-value substances include α-farnesene, vitamin B12, fumaric acid, linalool, glucaric acid, carminic acid, mycosporine-like amino acids, patchoulol, orcinol glucoside, d-lactic acid, keratinase, α-glucanotransferases, β-glucosidase, seleno-methylselenocysteine, fatty acids, high-efficiency β-glucosidase enzymes, cellulase, β-carotene, physcion, and glucoamylase. Additionally, recent advances in enzyme engineering for enhancing thermostability will be discussed. These findings have the potential to revolutionize various industries, including biotechnology, food, pharmaceuticals, and biofuels.

Keywords: protein and enzyme engineering; industrial biotechnology; thermostability; Escherichia coli ; Saccharomyces cerevisiae ; yeast; bacteria; fungi; algae

1 Introduction

Gene manipulation involves the use of biotechnological techniques to alter the genetic material of an organism, enabling the production of proteins with desired characteristics [1]. Protein engineering has evolved over many decades (Table 1), and gene manipulation is no longer a technical challenge. For instance, human genes can be successfully integrated into the genome of mice, and plant genes can even be introduced into bacterial and yeast cells. One of the notable breakthroughs was the work of Stanley Cohen and Herbert Boyer, who transferred a human gene encoding insulin into bacterial cells to produce insulin [2]. This achievement highlights the universal nature of life’s basic instructions, enabling the decoding of genetic information from various organisms to produce proteins. In the area of agriculture, protein engineering facilitates the creation of genetically modified plants (GMOs) with unique properties. Typically, their fruits are characterized by increased durability, enhanced taste, stronger aroma, resistance to pests, and adverse environmental conditions. A notable example is Flavr Savr, a breed of genetically modified tomatoes resistant to rot due to a transformed gene responsible for the production of an enzyme that breaks down the cell wall [3]. Flavr Savr has been approved and is available for human consumption. Genetic manipulation has also been used to create modified animals with increased growth hormone levels, which quickly grow to large sizes, thereby reducing breeding costs in the long run [4].

Table 1

Major milestones in the progression of protein engineering

Year/decade Milestone Description Reference
1953 Discovery of DNA structure by Watson and Crick Laid the foundation for understanding the relationship between genes and proteins [7]
1960s Development of recombinant DNA technology Enabled isolation, manipulation, and expression of specific genes, opening avenues for targeted protein modifications [8]
First successful protein engineering experiment Anfinsen et al. refold and reactivated a denatured ribonuclease, demonstrating the possibility of manipulating protein structure and function [9,10]
1970s Development of site-directed mutagenesis Introduced specific mutations into sequences, enabling targeted changes in protein function [11]
Emergence of rational design Used structural information to predict the effects of mutations on protein structure and function, guiding the design of new proteins [12,13]
1980s Directed evolution Mimicked natural selection in the lab, creating protein libraries with diverse mutations and selecting variants with desired properties [14]
Discovery of protein folding codes Identified general principles governing protein folding, fueling efforts in de novo protein design [15]
1990s Development of computational tools for protein structure prediction and design Advanced computing power and algorithms enabled more accurate predictions of protein structures [16]
First de novo designed proteins Researchers successfully created functional proteins from scratch using computational design methods. [17]
2000s High-throughput screening Automated platforms accelerated the identification of desired protein variants from large libraries [18]
Expansion of protein engineering applications Extended beyond enzyme optimization into areas like biomaterials development, biosensors, and therapeutic protein design [19,20]
2010s–Present Machine learning and artificial intelligence integration Advanced algorithms improved protein structure prediction, guided rational design, and facilitated protein function prediction [21]
Non-canonical amino acid incorporation Expanded the building blocks of proteins, enabling novel functionalities [22]
Focus on protein–protein interactions Engineering protein–protein interactions holds promise for new therapeutic strategies and functional materials [23]
Looking forward Continued advancements Expected in computational tools, automation, and protein engineering techniques, accelerating the development of proteins with tailored properties for diverse applications

Designing new proteins with desired functions is a complex task, but it can yield significant benefits to the pharmaceutical, biomedical, and other industries. While medical applications currently represent the most lucrative market for engineered protein products, synthetic enzymes are also utilized in the food industry for processing. Moreover, engineered enzymes have been employed in industries to detoxify pollutants such as plastics [5]. The vast sequence space and numerous structural constraints are the major factors that make designing improved proteins difficult. Factually, a protein composed of 100 amino acids can indeed have about 10130 possible variants, the vast majority of which are non-functional [6]. High-throughput biochemical assays and sequencing technologies have accelerated large-scale genetic screening, which is crucial for protein engineering. This has allowed for an in-depth exploration of the relationships between protein structure and function under conditions of controlled selective pressure. Such pressures could be external factors like temperature, pH, or substrate concentration, which are critical in the design and optimization of proteins for specific applications. This approach has significantly enhanced the understanding of protein evolution, adaptation, and other biological phenomena, paving the way for the development of novel proteins with desired properties.

The fundamental principle of protein engineering involves modifying sequences through methods, such as direct evolution, rational design, and de novo design (Figure 1). These modifications aim to enhance the catalytic activity, stability, and selectivity, thereby improving the enzyme cascade system. Significant progress has been made in protein (enzyme) engineering methods, with current techniques showing notable improvements over traditional methods (Table 2). Emerging frontiers in enzyme immobilization, computational enzyme design, multi-enzyme systems, synthetic biology, and genome editing hold promise for further advancements in enzyme engineering. With continued research and innovation, enzyme engineering has the potential to revolutionize a wide range of industries, leading to a greener and more sustainable future.

Figure 1 Overview of protein engineering for improved enzyme properties.
Figure 1

Overview of protein engineering for improved enzyme properties.

Table 2

Comparison between the current protein engineering methods and traditional methods

Traditional methods New methods
Overview Traditional protein engineering involves rational protein design and directed evolution. It often requires detailed knowledge of the structure and function of a protein New advances leverage computational protein design to create new proteins and functions in silico [24]. They also use machine learning and artificial intelligence [25,26]
Advantages Traditional methods are inexpensive and technically easy, as site-directed mutagenesis methods are well-developed New methods accelerate the process, reduce costs, and enable more sophisticated engineering goals. They can also produce protein chains up to 164 amino acids long rapidly (Hartrampf et al., [27])
Limitations The major drawback is that detailed structural knowledge of a protein is often unavailable. Even when available, it is very difficult to predict the effects of various mutations While the sequence-conformation space that needs to be searched is large, the most challenging requirement for computational protein design is a fast yet accurate energy function
Applications Traditional methods have been used to improve the function of many enzymes for industrial catalysis New methods have been applied in the design of novel protein variants incorporating amino acids that do not occur naturally in cells [28]. They have also been used in the development of biocatalysts for industrial applications

To promote the industrial use of enzymes, several crucial factors must be considered, including catalytic efficiency, substrate specificity, and stability [26,29]. Catalytic efficiency is a fundamental component of enzyme engineering, where it decisively influences the rate and efficacy of enzymatic reactions [30,31]. In the field of industrial biotechnology, the need for highly efficient enzymes presents new challenges, particularly the necessity to significantly increase catalytic turnover (k cat) or efficiency (k cat/K m). Substrate specificity, on the other hand, is a crucial element in enzyme engineering. It refers to an enzyme’s capacity to selectively bind and catalyze a particular substrate over others. This specificity is dictated by the unique three-dimensional structure of the enzyme’s active site, which is specifically designed to accommodate certain substrates [32]. In an industrial context, this specificity ensures that engineered enzymes execute their intended reactions with efficiency and selectivity, thereby minimizing undesired side reactions. For example, in the pharmaceutical industry, enzymes exhibiting high substrate specificity are employed to synthesize drugs, resulting in fewer impurities. Similarly, stability against heat and organic solvents is particularly important due to the harsh conditions of industrial processes. Directed evolution has been instrumental in enhancing catalytic properties, and efforts have been made to create enzymes with new catalytic functions for non-natural reactions. Rational design, computational methods, and directed evolution have been combined to achieve this goal. Likewise, substrate channeling, an approach that directs intermediates to the next-stage enzymes, has been explored to enhance reaction rates and conversion yields in multi-enzyme processes [33]. Various strategies, including co-localization of enzymes and the use of scaffold molecules, have also been employed to facilitate substrate channeling and increase product yield.

In recent years, protein/enzyme engineering has seen numerous advancements, resulting in remarkable outcomes with potential for industrial application. This review aims to spotlight these recent achievements. It specifically explores the application of bacteria, yeasts, fungi, and algae systems in enzyme engineering. Additionally, it highlights recent bioengineering efforts to enhance thermostability, a critical factor for production efficiency [34]. Overall, this review intends to enrich the awareness of scientists, industries, and stakeholders about current developments in this very important field.

1.1 Metabolic engineering in Escherichia coli for the biosynthesis of specific compounds

E. coli is a versatile and well-studied bacterium that has been extensively employed in biotechnology for the production of various industrially important compounds. Recent advancements in metabolic engineering have further highlighted the versatility of E. coli in diverse bio-based chemical productions, leading to promising results in enhancing bio-products such as γ-aminobutyric acid (GABA), shikimate, d-allulose, monophosphoryl lipid A (MPL), caffeic acid, α-aminoadipic acid (AAA), lipoic acid (LA), l-arginine, erythritol, 2-phenylethanol, hydroxytyrosol (HT), 2′-fucosyllactose (2′-FL), cis-3-hydroxypipecolic acid (cis-3-HyPip), and various valuable compounds routed from heme biosynthesis using whole-cell biocatalysis. Yang et al. recently demonstrated the remarkable potential of E. coli in enhancing GABA production through a combination of enzyme evolution and metabolic engineering techniques [35]. By developing mutants of glutamate decarboxylase (GadBM4), a 20.27% increase in GABA productivity in one of the mutants (GadBM4-2) was achieved. Further improvement in GABA production was achieved by introducing the regulator GadE and enzymes from the pathway for the synthesis of pyridoxal 5′-phosphate. This resulted in a remarkable 24.92% increase and reached 76.70 g/L/h with high conversion efficiency. In a 5-L capacity bioreactor, the concentration of GABA in the fermentation broth reached an impressive 307.5 ± 5.94 g/L, with a production rate of 61.49 g/L/h when crude l-glutamic acid was used as the substrate. The versatility of E. coli extends to the production of shikimate, as demonstrated by Li et al. [36], where, using a comprehensive approach, they identified and utilized ten key target genes to promote metabolic flux towards shikimate biosynthesis [36]. The engineered E. coli strain, SA05, achieved a remarkable shikimate production of 78.4 g/L. Further optimization reduced unwanted by-products and enhanced shikimate productivity by 23.2%. In a 30-L fermenter, SA09 achieved a notable shikimate titer of 126.4 g/L, a glucose yield of 0.50 g/g, and 2.63 g/L/h productivity [36]. This finding establishes a new benchmark for shikimate production in E. coli, recording the highest titer and productivity to date. Likewise, Zhang et al. devised an efficient strategy for producing d-allulose using a catalyst developed by assembling the d-allulose synthetic cascade in the E. coli envelope, eliminating the need for costly purified enzymes and by-products. Process optimization strikingly improved the d-allulose titer by 1,500%, and the production was scaled up to a 3-L scale, yielding 5.67 g L−1 d-allulose [37]. This approach holds promise for sustainable d-allulose production. E. coli is also amenable to genetic modification to produce MPL, a key vaccine adjuvant [38]. By removing specific gene clusters and overexpressing selected genes, a new strain, MW012, was created and was further modified into MW012/pWEPL, which produced two MPL species, with the more effective hexa-acylated MPL constituting 75% [38]. This innovative method offers a potentially more productive and cost-efficient MPL production route, with significant implications for vaccine development and wider biotechnological applications.

The phenolic compound 3,4-dihydroxycinnamic acid, commonly known as caffeic acid, is a valuable precursor for a vast array of several high-value compounds. Caffeic acid was efficiently produced in an E. coli strain, CA3, engineered to express tyrosine ammonia-lyase, p-coumaric acid 3-hydroxylase, and feedback-resistant chorismate mutase/prephenate dehydrogenase. Using this strategy, CA3, directly converted glucose into caffeic acid, yielding 1.58 g/L without the need for tyrosine supplementation. To further enhance the yield, 4-hydroxyphenylacetate 3-hydroxylase was introduced, resulting in an engineered strain, CA8, that produced 6.17 g/L of caffeic acid directly from glucose [39]. The developed E. coli strain holds promise as a framework strain for the biosynthesis of caffeic acid derivatives. In another study, both nonproteinogenic and proteinogenic amino acids have been successfully produced in engineered E. coli strains to efficiently produce AAA by modifying lysine biosynthesis and degradation pathways [40]. Notably, transgenic enzymes from other organisms, including Saccharomyces cerevisiae and Rhodococcus erythropolis, were introduced, which enhanced lysine supply while improving AAA efflux using a glutamate transporter from Corynebacterium glutamicum. The engineered strain achieved high AAA production levels of 2.94 g/L in flasks subjected to shaking and 5.64 g/L in bioreactors [40]. This method offers a sustainable and cost-effective alternative to chemical synthesis for industries such as pharmaceuticals, chemicals, and animal feed. Just as caffeic acid is very important industrially, l-arginine’s versatile properties, from enhancing nitric oxide production to promoting protein synthesis, make it an indispensable ingredient in various industrial applications, ranging from pharmaceutical manufacturing to food production. To improve l-arginine production, Nie et al. employed a key strategy of directly feeding N-acetylglutamate to engineered E. coli, bypassing the regulation and metabolic complexity of l-arginine biosynthesis [41]. Gene disruption (argA, astA, speF, speB, and argR) and operon overexpression (argDGI and argCBH) enabled high-yield l-arginine production (4 g/L) with a yield of 0.99 mol l-arginine/mol N-acetylglutamate in shake flask fermentation. Additionally, the co-production of l-arginine and pyruvate (4 g/L l-arginine and 11.3 g/L pyruvate) was achieved by improving the utilization of input carbon sources [41]. These findings have a far-reaching impact on industrial production and metabolic engineering. Similarly, LA, otherwise known as α-LA (ALA), is also another valuable substance widely used as a nutraceutical, supplement, and drug, with high industrial demand. Lennox-Hvenekilde et al. engineered an E. coli strain to overcome the challenge of toxicity associated with producing LA [42]. The pathway for LA production involves three key enzymes, all of which are toxic when overexpressed in E. coli. To overcome this toxicity, they identified enzymes from Serratia liquefaciens, exhibiting high catalytic efficiency and no cytotoxicity. The optimized strain produced 2.5 mg of free LA per g of glucose in minimal media and reached an LA titer of 87 mg/L of free LA after 48 h of fed-batch fermentation [42]. This titer is approximately 3,000-fold higher than formerly reported free LA titers and has implications for the industrial production of LA [42].

Erythritol, a sugar alcohol used as a sugar substitute, cannot be metabolized by humans [43]. Due to incomplete absorption in the body, some erythritol can reach the large intestine, potentially causing digestive issues such as bloating, gas, and diarrhea, especially in individuals who consume large amounts of erythritol. Recently, a strain of E. coli has been engineered to metabolize erythritol as its sole carbon source [43]. The genetic components involved in erythritol metabolism were elucidated, and the erythritol-binding transcriptional repressor and its target DNA region were studied. Transcriptome analysis reveals upregulation of carbohydrate metabolism genes, including transketolase (tktA and tktB) and transaldolase (talA and talB) genes. Overexpressing these genes led to a threefold increase in E. coli growth [43]. The genetically modified E. coli strains function as sensors for erythritol-containing soda soft drinks and exhibit the ability to proliferate in simulated intestinal fluid containing erythritol. These findings open possibilities for applications in synthetic biology, metabolic, and biomedical engineering. In a recent study, two heterologous pathways in E. coli have been constructed to produce 2-phenylethanol (2-PE) from glucose, where the Ehrlich pathway performed better and resulted in a higher titer [44]. The pathway was modified by deleting feaB and knocking out crr and pykF genes, which led to a 35% increase in titer. A plasmid-free strain was constructed with multiple ARO10 cassettes and overexpression of the yjgB gene, demonstrating exceptional performance in de novo 2-PE synthesis in E. coli. It achieved a yield of 0.076 g/g glucose and a productivity of 0.048 g/L/h, outperforming all previously reported values [44]. The resulting strain portrays the potential to produce higher titers with further fermentation optimization. Similarly, combinatorial metabolic engineering and tolerance evolving were employed to engineer the MG1655 E. coli strain to achieve a high 2′-FL production [45]. Precise regulation of gene expression in the 2′-FL synthesis pathway was achieved by employing single or multiple gene copies based on the identification of rate-limiting enzymes. This guided the elimination of competing branch pathway genes and the optimization of 2′-FL efflux protein SetA and fructose-1,6-bisphosphatase GlpX overexpression. This strain yielded an impressive 46.06 ± 1.28 g/L of 2′-FL in a 5-liter fermenter. Further refinement through adaptive laboratory evolution resulted in rpoC gene mutation that enhanced cell tolerance and boosted 2′-FL production to 61.06 ± 1.93 g/L. This established the highest productivity of 1.70 g/L/h among E. coli strains reported to date. Likewise, a genetically engineered E. coli strain produced HT, a valuable polyphenolic molecule [46]. The modified strain carries two plasmids that enhance the expression of key enzymes involved in HT production. The study showed that DOPA decarboxylase (DODC), alcohol dehydrogenases, monoamine oxidase, and glucose dehydrogenases are crucial for efficient HT biosynthesis. DODC from humans was found to be the most effective enzyme for HT production. Seven promoters were strategically integrated to enhance the expression of catalase, a crucial enzyme that catalyzes the decomposition of hydrogen peroxide (H2O2), a potentially harmful by-product of cellular metabolism. After screening and optimization, coexpression strains with enhanced HT production were obtained. This outcome has significant implications for the industrial production of HT. The optimized whole-cell biocatalyst exhibited remarkable performance, achieving a maximum titer of 4.84 g/L of HT and demonstrating an outstanding molar substrate conversion rate of over 77.5% [46]. This approach offers a more sustainable method for meeting the high demand for HT in various industries.

To find an efficient and cost-effective method for the bio-based industrial production of cis-3-HyPip, two enzymes, Streptomyces malaysiensis cyclodeaminase and StGetF (Streptomyces pipecolic acid hydroxylase), were screened for their ability to convert l-lysine into cis-3-HyPip [47]. They were expressed in E. coli W3110 ΔsucCD (a strain capable of producing α-ketoglutarate) and overexpressed an NAD(P)H oxidase to create an NAD + regeneration system. This enabled the efficient bioconversion of cis-3-HyPip from low-cost substrate l-lysine without the need for additional NAD + and α-ketoglutarate. The efficiency of the cis-3-HyPip biosynthetic pathway was also improved by optimizing multiple-enzyme expression and regulating transporter dynamics. The resultant strain, HP-13, achieved a remarkable production level of 78.4 g/L of cis-3-HyPip with a conversion rate of 78.9% [48], which is the highest reported so far. Likewise, successful whole-cell P450 biocatalysis using engineered E. coli and fine-tuned heme biosynthesis was recently reported [49]. Key strategies encompassed improving intracellular heme biosynthesis through synthetic gene expression and DNA-guided scaffolds, fine-tuning intracellular heme levels using mutated heme-sensitive biosensors and small regulatory RNA systems, and enhancing catalytic efficiencies of three P450s, namely, CYP105D7, BM3, and sca-2 [49]. The findings indicate that insufficient heme supply limits the activity of whole-cell P450 biocatalysis. This research has potential industrial applications, providing a strategy for developing whole-cell biocatalysts for chemical intermediates, drugs, and natural products. Overall, these achievements underscore the significance of E. coli in sustainable and efficient production processes. Furthermore, they offer valuable insights and methodologies, propelling the application of E. coli in sustainable and cost-effective industrial biotechnology.

1.2 Enzyme and metabolic engineering for the production of valued compounds in S. cerevisiae and other yeasts

S. cerevisiae, akin to E. coli, has been a foundation of recent advancements in protein engineering, enabling the efficient production of valuable substances. For instance, yeasts have been used to enhance the production of carotenoids and microbial fats [50,51,52]. Vitamin B12 is indisputably an essential material in many foods and pharmaceutical industries and is in high demand. A vitamin B12-dependent S. cerevisiae strain was developed by substituting the B12-independent methionine synthase gene with its B12-dependent counterpart from E. coli. Furthermore, a highly efficient bacterial flavodoxin/ferredoxin-NADP + reductase (Fpr-FldA) system was introduced and is essential for the in vivo reactivation of the MetH enzyme activity and yeast cell growth [53]. This engineered strain can only grow on methionine-free media when adenosylcobalamin or methylcobalamin is added. Notably, a heterological vitamin B12 transport system is not necessary for the uptake of cobalamin in these yeast cells. This result holds serious implications for industrial vitamin B12 production, as S. cerevisiae can be utilized as a host for heterological vitamin B12 production. Similarly, α-farnesene, a versatile natural sesquiterpene, finds applications in various industries, including fragrances, cosmetics, flavorings, insect repellents, pheromones, biofuels, pharmaceuticals, plastics, and agrochemicals. In recent research, an efficient α-farnesene-producing S. cerevisiae using metabolic engineering was created [54]. Camellia sinensis α-farnesene synthase (CsAFS) proved most effective, and the precursor supply was boosted by improving the mevalonate pathway. The introduction of CsAFSW281C and a serine–lysine–isoleucine–lysine peptide tagged to the N-terminal further optimized production [54], yielding 2.8 g/L in shake-flask cultures and 28.3 g/L in bioreactor fermentation. The applications span across agriculture, fuel, and chemical industries. Fumaric acid is utilized as an acidulant in food and beverages, pharmaceuticals, resins, polymers, cosmetics, animal feed, and cleaning products. By disrupting the natural FUM1 gene and the introduction of genes for fumarase and malate transporter, a genetically modified S. cerevisiae that converts malic acid into fumaric acid was created [55]. The origin of the fumarase gene, the presence of the XYNSEC signal secretion peptide, and the maintenance of aerobic conditions during cultivation were all critical factors contributing to the successful outcome. Under aerobic conditions, the two strains ΔFUM1(ss)Ckr_fum + mae1 and ΔFUM1Ckr_fum + mae1 efficiently transformed extracellular malic acid into fumaric acid, achieving yields of 0.98 and 1.11 g/L, respectively.

Another industrially important chemical is Linalool, which is widely used in fragrances, flavors, perfumes, soaps, shampoos, and cleaning agents for its pleasant floral scent. Through protein engineering, modifications to the substrate-binding pocket of linalool synthase were made by introducing specific mutations (F447E and F447A). These alterations were employed to enhance the catalytic efficiency toward geranyl pyrophosphate. The strategy led to a substantial 2.2 and 1.9-fold increase in linalool production, respectively [56]. By compartmentalizing linalool synthesis in both the cytoplasm and peroxisomes of S. cerevisiae, a significant improvement in precursor molecule availability and optimized linalool production was achieved. The genetically enhanced strain achieved an impressive production level of 219.1 mg/L during shake-flask cultivation. Furthermore, in a 5-L capacity fed-batch fermentation, the diploid strain surpassed all previous records, reaching a linalool titer of 2.6 g/L, the highest reported production in the yeast system. These findings carry potential implications for the microbial manufacture of other monoterpenes and can be applied in industrial settings for sustainable and scalable linalool production. Glucaric acid’s biodegradability, non-toxicity, and potential to replace harmful substances make it an industrially relevant platform with applications in detergents, corrosion inhibitors, and pharmaceuticals. The fusion of MIOX4 and Udh enzymes, linked by the peptide (EA3K)3, in S. cerevisiae strain, GA16, enhanced the biosynthesis pathway of glucaric acid, achieving a 4.9 g/L titer value during shake flask fermentation [57]. Further engineering to regulate myo-inositol metabolism increased production, with strain GA-ZII producing 8.49 g/L in shake flask fermentation and 15.6 g/L in a 5-L bioreactor through fed-batch fermentation. Similarly, carminic acid, a natural colorant with enduring vibrancy and stability, finds diverse applications in food, cosmetics, pharmaceuticals, textiles, and art, driven by its sustainability. Through systematic pathway engineering in S. cerevisiae, a record carminic acid titer of 7580.9 μg/L was achieved in a 5-L capacity bioreactor [58]. This innovation opens up the possibility of environmentally friendly carminic acid production with higher yields and consistent quality, impacting the food and cosmetics industries. In the area of cosmetics and skincare, mycosporine-like amino acids (MAAs) are gaining traction as natural UV protectants, replacing synthetic sunscreens that may cause skin irritation or allergies. Their ability to absorb UV rays without harming the skin makes them a desirable choice. Recently, biosynthetic genes from cyanobacteria were integrated into S. cerevisiae to create a MAA-producing strain [59]. By introducing mysD genes, it was discovered that different MysD enzymes efficiently produce specific MAAs. MysD substrate specificity is determined by a 43-45 amino acid omega loop region. This research successfully demonstrates the production of MAAs in S. cerevisiae, including porphyra-334 and M2G, for the first time. In fermentation, the engineered strains achieved high titers of shinorine and porphyra-334, up to 1.53 and 1.21 g/L, respectively [59], offering a sustainable and environmentally friendly option for natural sunscreen development.

Apart from S. cerevisiae, other yeasts have applications in industrial bioengineering. For instance, recently, Komagataella phaffii (also known as Pichia pastoris), a methylotrophic yeast, was metabolically engineered for the overproduction of patchoulol [60]. Patchoulol holds industrial relevance in the fragrance and cosmetics industry, imparting a distinctive and enduring aroma to diverse products. The result showed that strain P6H53 produced 149.64 mg/L of patchoulol in shake-flask fermentation. In a 5-L capacity fermenter, P6H53 achieved a patchoulol yield of 2.47 g/L, and 21.48 mg/g DCW, in addition to a production rate of 283.25 mg/L/day. This research suggests the potential for industrial application and provides insights into high-yield patchoulol production in K. phaffii utilizing methanol as the source of carbon. Similarly, a dimorphic oleaginous, Yarrowia lipolytica, was recently metabolically engineered for improved application in the production of orcinol glucoside (OG). OG, known for its antidepressant activity, has industrial interests, primarily in the pharmaceuticals. This alteration in the Yarrowia lipolytica resulted in a 100-fold increase in OG production, yielding 43.46 g/L (0.84 g/g DCW) [61]. Finally, genome engineering of the yeast Kluyveromyces marxianus aimed to produce a high titer and yield of d-lactic acid under low pH without growth defects [62]. d-lactic acid, a versatile chiral organic compound, holds immense industrial potential in biodegradable plastics, food, pharmaceuticals, leather, dairy, and chemical industries, but cost-effective production remains an obstacle. Strategies used included genetic modification, optimized fermentation conditions, and resource utilization. Interestingly, the engineered strain, KMΔpdc1: ldhA, solely produced d-lactic acid without by-products. Aeration rate, pH, and temperature were optimized for a maximum d-lactic acid titer of 42.97 ± 0.48 g/L, obtained from glucose. Thermotolerance was also observed at 42°C. Sugarcane molasses proved to be a viable nutrient-less medium, yielding 66 g/L of d-lactic acid at 30°C. This engineered strain demonstrates scalability, cost-effectiveness, and potential for industrial production. Overall, the versatile yeast S. cerevisiae and other yeasts proved instrumental in industrial bioengineering, exemplified by the development of the vast array of valuable substances with scalable industrial applications.

1.3 Engineering other bacteria, fungi, and algae for the biosynthesis of specific compounds

E. coli is arguably the most prominent bacterium for industrial applications, as is S. cerevisiae for yeasts. However, other organisms, though not as prominent, also have spectacular applications in bioengineering with scalable industrial potential. Here, reference is made to the recent use of some of these other organisms to improve the production of valued substances. To overcome challenges in keratinase production and biomass generation hindering industrial use, a growth-dependent system in Bacillus subtilis was devised [63]. Utilizing quorum sensing and the P aprE promoter, keratinase production was effectively delayed to promote host cell proliferation. Equilibrium between cell growth and keratinase production was optimized through copy number screening and core region mutations. The system’s efficiency was improved by the addition of 2% glucose during the early fermentation stage, significantly facilitating biomass accumulation. The successful implementation of this growth-dependent system enabled increased cell density from 8 to 15.6 and a rise in keratinase activity from 1,162 to 4,200 U·mL−1 [63]. The practical application of the system demonstrated feather waste conversion, resulting in the production of soluble keratins, amino acids, and polypeptides. B. subtilis was also useful in the recent strategy to enhance selenocysteine (SeCys) biosynthesis for efficient production of seleno-methylselenocysteine (SeMCys), which has applications in selenium supplementation [64]. Selenium supplementation was shown to have promising effects on critically ill patients by altering inflammatory markers and its antioxidant properties. Selenium influences the biosynthesis of proteins in cells, leading to differential protein expression, and induces lipid peroxidation [65,66,67,68,69,70]. Intracellular accumulation of SeCys was achieved by overexpressing serine O-acetyltransferase and optimizing the S-adenosylmethionine (SAM) synthetic pathway via enhancing SAM synthetase expression. SeMCys was successfully produced by expressing selenocysteine methyltransferase in a strain accumulating both SeCys and SAM. Integration of necessary genes yielded SeMCys production at 18.4 μg/L. This lays the foundation for further pathway engineering for large-scale SeMCys production, with significant implications for supplementation and pharmaceuticals in the industry. Lactococcus lactis metabolic engineering has demonstrated the first successful extracellular production of 4,6 and 4,3 α-glucanotransferases [71]. The enzymes have Generally Recognized as Safe status and are potentially useful for industrial applications, particularly in starch retrogradation delay and reduction of glycaemic index.

In Clostridium cellulolyticum, genetic engineering, and CRISPR-Cas9n were employed to enhance cellulose degradation. Cellulose degradation, a vital natural process facilitated by microorganisms, possesses significant industrial importance. This process enables the production of biofuels, paper, textiles, biochemicals, and solutions for wastewater treatment. By integrating a more efficient β-glucosidase and disrupting the expression of lactate dehydrogenase (ldh), the manipulated strain showed a 7.4-fold enhancement in β-glucosidase activity and a 70% reduction in lactate production [72]. It exhibited a 12% improved degradation of cellulose and a 32% higher ethanol production rate compared to the wild-type. The study identifies ldh as a potential locus for heterologous expression, proving the effectiveness of this strategy. Similarly, in different research aimed at enhancing cellulose degradation, genetically engineered Lactobacillus lactis strains, NZ9000s, were created to express and produce high-efficiency β-glucosidase enzymes. These enzymes basically comprised of three subunits (BglA, BglB and Bgl) of β-glucosidase found in yak rumen microorganisms [73]. The engineered strains showed impressive efficient hydrolysis of cellulose through the production of β-glucosidase enzymes [73].

β-Carotene is important industrially as a provitamin A source, and is widely used in food, cosmetics, pharmaceuticals, and animal feed. The filamentous fungus Trichoderma reesei was recently engineered to simultaneously produce cellulase and β-carotene [74], offering dual benefits for industrial applications. The approach involved overexpressing four key enzymes, including CarRP, HMG1, GGS1/CrtE, and CarB, resulting in β-carotene production, attaining 218.8 mg/L titer in flask culture and 286.63 mg/L in a jar system, along with cellulase production of 22.33 IU/mL [74]. Similarly, glucoamylase, a vital enzyme for saccharification of starch, is mainly produced by mesophilic fungi in the biofuel and food industries. The thermophilic fungi, Myceliophthora thermophila was recently engineered, with improved AsCas12a variants to develop a platform for the high production of glucoamylase in M. thermophila [75]. Gene deletions created the strain MtGM12, with a significant increase in glucoamylase secretion and activity compared to the wild-type strain. In agriculture, physcion is potentially an ecofriendly fungicidal alternative for pest and disease management in crops. The enzyme O-methyltransferase enzyme AcOMT was recently identified and employed to de novo biosynthesize the natural fungicide physcion, by optimizing the biosynthetic pathway in Aspergillus nidulans. Basically, emodin biosynthesis was used as a probe to identify AcOMT, which is capable of converting emodin into physcion. The introduction of AcOMT into A. nidulans, along with expressed decarboxylase genes, achieved a physcion titer of 64.6 mg/L in shake-flask fermentation [76]. The biosynthetic pathway was optimized by expressing decarboxylase genes from different fungi.

Ketocarotenoid accumulation in the green algae Chlamydomonas reinhardtii holds significant industrial relevance by enabling the production of valuable compounds. Such compounds include astaxanthin, improving tolerance to highlight conditions, offering the potential for genetic modification to enhance carotenoid content, and contributing to the generation of bioactive compounds with diverse applications. This positions the microalga as a promising candidate for industrial use. Recently, C. reinhardtii was metabolically engineered for efficient ketocarotenoid accumulation. The strategies include a systematic screening of synthetic transgene designs that target carotenoid pathway enzymes, the identification of phytoene synthase (PSY/crtB) as a limiting factor, and the enhancement of β-carotene hydroxylase (CHYB) activity to promote the accumulation of engineered astaxanthin. The implementation of a unified BKT, crtB, and CHYB expression strategy yielded a 4-fold enhancement in volumetric astaxanthin production compared to preceding studies [77]. Overall, B. subtilis, C. cellulolyticum, L. lactis, T. reesei, M. thermophila, and C. reinhardtii are just a few examples of organisms that, apart from E. coli and S. cerevisiae, demonstrate the diversity and applicability of bioengineering efforts to enhance the production of valuable substances.

2 Enzyme engineering for enhanced thermostability

There are many parameters that are crucial to the efficiency of enzymes used for industrial applications, including pH, solvent, temperature, substrate concentration, enzyme concentration, cofactors, and coenzymes. However, the thermostability of enzymes is an exceptionally crucial necessity for enzyme efficiency, as many industrial processes often require high temperatures. Extremophiles, organisms thriving in extreme environments, have been discovered to produce enzymes with high stability against heat, salts, and pH, providing valuable insights for designing stable enzymes. Recently, researchers have discovered ways to improve the thermostability of enzymes. For instance, through rational engineering, two mutations (D28N and D116N) that enhanced the thermostability (6.1 and 9.2°C increase, respectively) and activity of a metalloprotease enzyme were identified using molecular dynamics simulation [78]. The mutants demonstrated increased stability, higher melting temperatures, longer half-lives (1.07- and 1.8-fold higher) at high temperatures, and improved synthetic activity. Increased interactions due to hydrogen bonds and regional hydration shells contributed to the enhanced thermostability. Similarly, isothermal compressibility (β T) perturbation engineering (ICPE) was employed in engineering a variant of T1 lipase with enhanced thermostability and activity [79]. ICPE is a strategy that aims to understand the stability-activity trade-off in enzymes and develop variants that exhibit both high activity and stability. The most promising variant, A186L/L188M/A190Y, exhibited a high melting temperature (T m) of 78.70°C, a catalytic activity of 474.04 U/mg, and a 73.33% increase in resistance to dimethyl sulfoxide compared to the wild-type [79]. Bacillus amyloliquefaciens alpha-amylase is widely used in food and cleaning industries and was enhanced for thermostability by introducing multipoint mutations. The resultant mutant enzyme, MuBAA (D28E/V118A/S187D/K370 N), demonstrated superior thermostability and a 99.1% increase in specific activity (206.61 U/mg) compared to the wild-type [80]. Its enhanced thermostability was attributed to structural changes, including stabilization of a loop region in domain B and additional intramolecular interactions in domains A and B.

Two engineering approaches were used to improve the thermostability of polyethylene terephthalate (PET) hydrolase enzymes, which are crucial for efficient and cost-effective PET degradation and recycling. The first approach involved covalently cyclizing Ideonella sakaiensis PETase (IsPETase) using SpyCatcher-SpyTag technology, which increased thermostability but reduced PET substrate turnover [81]. The second approach utilized a GFP-nanobody fusion protein (vGFP) as a scaffold, yielding a construct with an 80°C melting temperature, which further improved to 85°C when a thermostable PETase variant (FAST PETase) was incorporated. This is the highest reported thermostability for an engineered IsPETase-derived PET hydrolase. Notably, the vGFP scaffold-enhanced thermostability did not compromise PET hydrolase activity, indicating that scaffold choice impacts both thermostability and enzymatic activity. These findings have industrial implications, as thermostable PET hydrolase enzymes can improve PET degradation efficiency and robustness. This reduces enzyme quantities needed for recycling, contributing to more sustainable and environmentally friendly PET recycling practices. Recently, also, Protein Repair One-Stop Shop algorithm was employed to engineer a thermostable variant of mFMO, a flavin-containing monooxygenase (FMO). By introducing 8 to 28 mutations, seven mutant variants of mFMO were generated, resulting in increased melting temperatures ranging from 4.7 to 9.0°C [82]. The most thermostable variant, mFMO_20, exhibited a crystal structure with four new stabilizing interhelical salt bridges involving mutated residues. Notably, mFMO_20 outperformed the native mFMO in reducing trimethylamine (TMA) levels in a salmon protein hydrolysate at industrially relevant temperatures. By enzymatically converting TMA into the odorless trimethylamine N-oxide, the engineered mFMO variant presents a promising solution to address the issue of fish-like odor in marine by-product-derived protein hydrolysates. Similarly, the thermostability of d-carbamoylase from Nitratireductor indicus (NiHyuC) was enhanced through ancestral sequence reconstruction and consensus sequence analysis [83]. Iterative combinatorial mutagenesis generated mutant enzyme M4Th3 (S202P/E208D/R277L), which exhibited significantly increased thermostability compared to M4 [83]. M4Th3 has a half-life of 36.5 h at 40°C, while M4 only lasts 1.3 h. M4Th3 also achieves higher conversion rates, converting 96.4% of N-carbamoyl-d-tryptophan to d-tryptophan after 12 h at 40°C, compared to M4’s 64.1%. Molecular dynamics simulations elucidate that the E208D mutation enhances hydrophobicity, while the R277L mutation improves the protein’s homodimeric structure stability. These findings have significant implications in the industrial “hydantoinase process” for synthesizing optically pure amino acids.

The thermal stability of sucrose isomerase from Erwinia rhapontici NX-5 was increased by a combination of strategies. Nineteen high B-value amino acid residues were identified and subjected to site-directed mutagenesis. The modified enzyme mutants (K174Q, L202E, and K174Q/L202E) were expressed and characterized in Pichia pastoris X33, demonstrating improved thermal stability with optimal temperatures increasing by 5°C and half-lives increasing 2.21, 1.73, and 2.89 times, respectively [84]. The mutant enzymes also showed increased activity by 20.3% to 25.3% and decreased K m values by 5.1, 7.9, and 9.4%, resulting in up to 16% higher catalytic efficiency. The comprehensive strategy used in this study can be applied to enhance the thermal stability of other enzymes. In a similar strategy, the thermostability of L-asparaginase (ASNase) was enhanced by mutating three key residues (Gly97, Asn159, and Glu249) to TYQ. This resulted in a triple mutant enzyme that was significantly more thermostable than the wild-type enzyme [85]. Molecular dynamics and structural analysis revealed that the added hydrogen bonds, increased hydrophobic interactions, and advantageous electrostatic potential contributed to the enzyme’s increased rigidity and thermostability. Finally, to improve UDP-glucose synthesis, the thermostability of sucrose synthase (Susy) from Nitrosospira multiformis was improved using automated prediction and greedy accumulation of beneficial mutations. The mutant Susy (M4) exhibited 27-fold increased T1/2 value at 55°C, allowing for UDP-glucose synthesis at 37 g/L/h [86]. Molecular dynamics simulations revealed that newly formed interfaces, particularly involving residue Trp162, strengthened subunit interaction. Overall, enhancing enzyme thermostability through molecular manipulation of inter-residue interactions holds significant promise for their industrial applications.

3 Future perspectives

Precision engineering and artificial intelligence can enhance enzyme activity and predictability [25,87]. For instance, a novel AI tool, referred to as CLEAN, surpasses top-tier tools in terms of precision, dependability, and responsiveness [88]. This tool utilizes the language inherent in proteins to predict their activity. CLEAN has the capability to forecast the roles of enzymes that have not been previously defined. It can rectify inaccuracies in enzyme labeling and accurately pinpoint enzymes that possess dual or multiple functions. Furthermore, machine learning can utilize the amino acid sequences of enzymes that are structurally similar but functionally different as input data, enabling efficient progression toward the desired function. This could potentially offer a fresh, fundamental understanding of the specificity between enzymes and substrates.

Furthermore, the study of microbial communities can lead to the development of efficient enzyme consortia. This, combined with the integration of enzymes with nanomaterials and synthetic biology, can unlock new functionalities and refine production methods. The focus of future engineering will be on enhancing enzyme tolerance and compatibility with unconventional substrates, thereby transforming waste into valuable products. Interdisciplinary collaboration will be pivotal in optimizing enzyme structure-function relationships and refining production processes. Tailored enzyme properties, directed evolution, and computational approaches will broaden the enzyme repertoire to cater to diverse industrial needs. The implementation of multi-enzyme cascades, immobilization techniques, novel reactor designs, and engineered enzymes will streamline complex synthesis pathways, enable continuous processes, and facilitate bioremediation. Enzyme-based biosensors will offer real-time process monitoring, contributing to the production of sustainable materials and biofuels. In the healthcare sector, the development of personalized therapeutics based on engineered enzymes will revolutionize treatment approaches. Collectively, these advancements will align industrial practices with the principles of sustainability and efficiency, marking a new era in protein engineering.

Protein engineering has indeed catalyzed a revolution in industrial applications, yet it is not devoid of challenges when it comes to the utilization of these modified proteins. A primary obstacle is the substantial cost incurred due to the complex procedures and specialized equipment required. Another concern is the stability of these engineered proteins; they may lose functionality if environmental conditions such as temperature or pH levels fluctuate. Additionally, there is the potential for unforeseen consequences. These proteins could interact with other molecules unpredictably, which might lead to detrimental effects. The process of obtaining regulatory approval for these proteins can be protracted and rigorous, especially for applications in the food and pharmaceutical industries. Ethical considerations also come into play, as the employment of GMOs in protein engineering is a contentious issue and often encounters public resistance. It is also crucial to note that safety concerns, legal regulations, and societal biases present distinct challenges. Independent experiments on microorganisms, which are a relatively recent development, could potentially provoke strong responses from governmental bodies. Despite this, many regulations continue to prohibit even the most basic genetic manipulations, such as bacterial transformation with a plasmid, outside of designated research facilities. Nevertheless, despite these obstacles, the benefits conferred by protein engineering frequently outweigh the disadvantages, rendering it a field ripe for future investigation and advancement.

  1. Funding information: Authors state no funding involved.

  2. Author contributions: G.O.N.: conceptualization, methodology, review of literature, and writing – original draft. Q.W.: conceptualization, methodology, writing – review & editing, and supervision. N.O.O.: methodology, review of literature, and writing – original draft. O.C.A.: conceptualization, methodology, writing – review & editing, and supervision. T.N.N.: conceptualization, methodology, writing – review & editing, and supervision. C.I.N.: conceptualization, methodology, writing – review & editing, and supervision. A.N.M.: conceptualization, methodology, writing – review & editing, and supervision. A.S.O.: conceptualization, methodology, review of literature, writing – original draft, and writing – review & editing.

  3. Conflict of interest: Authors state no conflict of interest.

  4. Data availability statement: Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.

References

[1] Robert JS, Baylis F. Genetic engineering. In: Heggenhougen HK, Quah SR, editors. International encyclopedia of public health. Amsterdam: Elsevier; 2008. p. 35–9.10.1016/B978-012373960-5.00133-7Search in Google Scholar

[2] Hughes SS. Making dollars out of DNA: the first major patent in biotechnology and the commercialization of molecular biology, 1974-1980. Isis. 2001;92(3):541–75.10.1086/385281Search in Google Scholar PubMed

[3] Feng J, Liang Y, Wang F, Chen J. Detection of genetically modified tomato using PCR coupled with muParaflo microfluidics microarrays. J Nanosci Nanotechnol. 2013;13(12):8266–74.10.1166/jnn.2013.7928Search in Google Scholar PubMed

[4] Ormandy EH, Dale J, Griffin G. Genetic engineering of animals: Ethical issues, including welfare concerns. Can Vet J. 2011;52(5):544–50.Search in Google Scholar

[5] Fouad FA, Youssef DG, Shahat FM, Abd El-Ghany MN. Role of microorganisms in biodegradation of pollutants. In: Ali GAM, Makhlouf ASH, editors. Handbook of Biodegradable Materials. Cham, Switzerland: Springer International Publishing; 2023. p. 221–60.10.1007/978-3-031-09710-2_11Search in Google Scholar

[6] Dryden DTF, Thomson AR, White JH. How much of protein sequence space has been explored by life on Earth? J R Soc Interface. 2008;5(25):953–6.10.1098/rsif.2008.0085Search in Google Scholar PubMed PubMed Central

[7] Sussman I. 65 years of the double helix: could watson and crick have envisioned the true impact of their discovery? Endocr Relat Cancer. 2018;25(8):E9–11.10.1530/ERC-18-0156Search in Google Scholar PubMed

[8] Johnson IS. Human insulin from recombinant DNA technology. Science. 1983;219(4585):632–7.10.1126/science.6337396Search in Google Scholar PubMed

[9] Richards FM, Christian B. Anfinsen (1916-95). Nature. 1995;376(6535):19.10.1038/376019a0Search in Google Scholar PubMed

[10] Thorp HH. Proteins, proteins everywhere. Science. 2021;374(6574):1415.10.1126/science.abn5795Search in Google Scholar PubMed

[11] Bachman J. Site-directed mutagenesis. Methods Enzymol. 2013;529:241–8.10.1016/B978-0-12-418687-3.00019-7Search in Google Scholar PubMed

[12] Korendovych IV. Rational and semirational protein design. Methods Mol Biol. 2018;1685:15–23.10.1007/978-1-4939-7366-8_2Search in Google Scholar PubMed PubMed Central

[13] Song Z, Zhang Q, Wu W, Pu Z, Yu H. Rational design of enzyme activity and enantioselectivity. Front Bioeng Biotechnol. 2023;11:1129149.10.3389/fbioe.2023.1129149Search in Google Scholar PubMed PubMed Central

[14] Balchin D, Hayer-Hartl M, Hartl FU. In vivo aspects of protein folding and quality control. Science. 2016;353(6294), aac4354.10.1126/science.aac4354Search in Google Scholar PubMed

[15] Tsai CJ, Ma B, Nussinov R. Folding and binding cascades: Shifts in energy landscapes. Proc Natl Acad Sci U S A. 1999;96(18):9970–2.10.1073/pnas.96.18.9970Search in Google Scholar PubMed PubMed Central

[16] Dong S, Sun J, Mao Z, Wang L, Lu Y, Li J. A guideline for homology modeling of the proteins from newly discovered betacoronavirus, 2019 novel coronavirus (2019‐nCoV). J Med Virol. 2020;92(9):1542–8.10.1002/jmv.25768Search in Google Scholar PubMed PubMed Central

[17] Ennist NM, Zhao Z, Stayrook SE, Discher BM, Dutton LP, Moser CC. De novo protein design of photochemical reaction centers. Nat Commun. 2022;13(1):1–10.10.1038/s41467-022-32710-5Search in Google Scholar PubMed PubMed Central

[18] Entzeroth M, Flotow H, Condron P. Overview of high-throughput screening. Curr Protoc Pharmacol. 2009;Chapter 9(Suppl. 44).10.1002/0471141755.ph0904s44Search in Google Scholar PubMed

[19] Tobin PH, Richards DH, Callender RA, Wilson CJ. Protein engineering: a new frontier for biological therapeutics. Curr Drug Metab. 2014;15(7):743–56.10.2174/1389200216666141208151524Search in Google Scholar PubMed PubMed Central

[20] Li C, Zhang R, Wang J, Wilson LM, Yan Y. Protein engineering for improving and diversifying natural products biosynthesis. Trends Biotechnol. 2020;38(7):729–44.10.1016/j.tibtech.2019.12.008Search in Google Scholar PubMed PubMed Central

[21] Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O, et al. Highly accurate protein structure prediction with AlphaFold. Nature. 2021;596(7873):583–9.10.1038/s41586-021-03819-2Search in Google Scholar PubMed PubMed Central

[22] Schultz P. Expanding the genetic code. Protein Sci. 2023;32(1):e4488.10.1002/pro.4488Search in Google Scholar PubMed PubMed Central

[23] Zahradník J, Schreiber G. Protein engineering in the design of protein-protein interactions: SARS-CoV-2 inhibitors as a test case. Biochemistry. 2021;60(46):3429–35.10.1021/acs.biochem.1c00356Search in Google Scholar PubMed PubMed Central

[24] Walker SP, Yallapragada VVB, Tangney M. Arming yourself for The In Silico Protein Design Revolution. Trends Biotechnol. 2021;39(7):651–64.10.1016/j.tibtech.2020.10.003Search in Google Scholar PubMed

[25] Feehan R, Montezano D, Slusky JSG. Machine learning for enzyme engineering, selection and design. Protein Eng Des Sel. 2021;34:1–10.Search in Google Scholar

[26] Kunka A, Marques SM, Havlasek M, Vasina M, Velatova N, Cengelova L, et al. Advancing enzyme’s stability and catalytic efficiency through synergy of force-field calculations, evolutionary analysis, and machine learning. ACS Catal. 2023;12506–18.10.1021/acscatal.3c02575Search in Google Scholar PubMed PubMed Central

[27] Hartrampf N, Saebi A, Poskus M, Gates ZP, Callahan AJ, Cowfer AE, et al. Synthesis of proteins by automated flow chemistry. Science. 2020;368(6494):980–7.10.1126/science.abb2491Search in Google Scholar PubMed

[28] Cheng L, Li D, Mai BK, Bo Z, Cheng L, Liu P. Stereoselective amino acid synthesis by synergistic photoredox-pyridoxal radical biocatalysis. Science. 2023;381(6656):444–51.10.1126/science.adg2420Search in Google Scholar PubMed PubMed Central

[29] Bell EL, Finnigan W, France SP, Green AP, Hayes MA, Hepworth LJ, et al. Biocatal Nat Rev Methods Primers. 2021;1(1):1–21.10.1038/s43586-021-00044-zSearch in Google Scholar

[30] Goldsmith M, Tawfik DS. Enzyme engineering: reaching the maximal catalytic efficiency peak. Curr Opin Struct Biol. 2017;47:140–50.10.1016/j.sbi.2017.09.002Search in Google Scholar PubMed

[31] Benítez-Mateos AI, Contente ML, Roura PD, Paradisi F. Flow biocatalysis 101: design, development and applications. React Chem Eng. 2021;6(4):599–611.10.1039/D0RE00483ASearch in Google Scholar

[32] Yoo YJ, Feng Y, Kim YH, Yagonia CFJ. Fundamentals of Enzyme Engineering. Dordrecht: Springer; 2017. p. 111–25.10.1007/978-94-024-1026-6_10Search in Google Scholar

[33] Svedružić ŽM, Odorčić I, Chang CH, Svedružić D. Substrate channeling via a transient protein-protein complex: the case of D-glyceraldehyde-3-phosphate dehydrogenase and L-lactate dehydrogenase. Sci Rep. 2020;10(1):1–12.10.1038/s41598-020-67079-2Search in Google Scholar PubMed PubMed Central

[34] Xu Z, Xue YP, Zou SP, Zheng Y. Enzyme engineering strategies to confer thermostability. Biomass, Biofuels, Biochemicals: Advances in Enzyme Catalysis and Technologies. Amsterdam, Netherlands: Elsevier; 2020. p. 67–89.10.1016/B978-0-12-819820-9.00005-3Search in Google Scholar

[35] Yang X, Huo X, Tang Y, Zhao M, Tao Y, Huang J, et al. Integrating Enzyme Evolution and Metabolic Engineering to Improve the Productivity of Γ-Aminobutyric Acid by Whole-Cell Biosynthesis in Escherichia coli. J Agric Food Chem. 2023;71(11):4656–64.10.1021/acs.jafc.2c07613Search in Google Scholar PubMed

[36] Li Z, Gao C, Ye C, Guo L, Liu J, Chen X, et al. Systems engineering of Escherichia coli for high-level shikimate production. Metab Eng. 2023;75:1–11.10.1016/j.ymben.2022.10.010Search in Google Scholar PubMed

[37] Zhang H, Zhao A, Qu L, Xiong W, Alam MA, Miao J, et al. Engineering an efficient whole-cell catalyst for d-allulose production from glycerol. Biotechnol J. 2023;18(7):2200600.10.1002/biot.202200600Search in Google Scholar PubMed

[38] Wang Z, Zhao A, Wang C, Huang D, Yu J, Yu L, et al. Metabolic engineering of Escherichia coli to efficiently produce monophosphoryl lipid A. Biotechnol Appl Biochem. 2023;70(3):1332–45.10.1002/bab.2443Search in Google Scholar PubMed

[39] Sakae K, Nonaka D, Kishida M, Hirata Y, Fujiwara R, Kondo A, et al. Caffeic acid production from glucose using metabolically engineered Escherichia coli. Enzyme Microb Technol. 2023;164:110193.10.1016/j.enzmictec.2023.110193Search in Google Scholar PubMed

[40] Zhang Y, An N, Zhao Y, Li X, Shen X, Wang J, et al. Efficient biosynthesis of α-aminoadipic acid via lysine catabolism in Escherichia coli. Biotechnol Bioeng. 2023;120(1):312–17.10.1002/bit.28256Search in Google Scholar PubMed

[41] Nie M, Wang J, Zhang K. A novel strategy for L-arginine production in engineered Escherichia coli. Microb Cell Fact. 2023;22(1):138.10.1186/s12934-023-02145-8Search in Google Scholar PubMed PubMed Central

[42] Lennox-Hvenekilde D, Bali AP, Gronenberg LS, Acevedo-Rocha C, Sommer MOA, Genee HJ. Metabolic engineering of Escherichia coli for high-level production of free lipoic acid. Metab Eng. 2023;76:39–49.10.1016/j.ymben.2023.01.004Search in Google Scholar PubMed

[43] Ba F, Ji X, Huang S, Zhang Y, Liu W, Liu Y, et al. Engineering Escherichia coli to utilize erythritol as sole carbon source. Adv Sci. 2023;10(14):2207008.10.1002/advs.202207008Search in Google Scholar PubMed PubMed Central

[44] Wang G, Wang M, Yang J, Li Q, Zhu N, Liu L, et al. De novo synthesis of 2-phenylethanol from glucose by metabolically engineered escherichia coli. J Ind Microbiol Biotechnol. 2022;49(6):kuac026.10.1093/jimb/kuac026Search in Google Scholar PubMed PubMed Central

[45] Sun X, Peng Z, Li C, Zheng Y, Cheng Y, Zong J, et al. Combinatorial metabolic engineering and tolerance evolving of Escherichia coli for high production of 2′-fucosyllactose. Bioresour Technol. 2023;372:128667.10.1016/j.biortech.2023.128667Search in Google Scholar PubMed

[46] Yan Y, Bai Y, Zheng X, Cai Y. Production of hydroxytyrosol through whole-cell bioconversion from L-DOPA using engineered Escherichia coli. Enzyme Microb Technol. 2023;169:110280.10.1016/j.enzmictec.2023.110280Search in Google Scholar PubMed

[47] Wang J, Wang Y, Wu Q, Zhang Y. Multidimensional engineering of Escherichia coli for efficient biosynthesis of cis-3-hydroxypipecolic acid. Bioresour Technol. 2023;382:129173.10.1016/j.biortech.2023.129173Search in Google Scholar PubMed

[48] Tang M, Pan X, Yang T, You J, Zhu R, Yang T, et al. Multidimensional engineering of Escherichia coli for efficient synthesis of L-tryptophan. Bioresour Technol. 2023;386:129475.10.1016/j.biortech.2023.129475Search in Google Scholar PubMed

[49] Hu B, Yu H, Zhou J, Li J, Chen J, Du G, et al. Whole-cell P450 biocatalysis using engineered escherichia coli with fine-tuned heme biosynthesis. Adv Sci. 2023;10(6):2205580.10.1002/advs.202205580Search in Google Scholar PubMed PubMed Central

[50] Gientka I, Kieliszek M, Jermacz K, Błażejak S, et al. Identification and characterization of oleaginous yeast isolated from kefir and its ability to accumulate intracellular fats in deproteinated potato wastewater with different carbon sources. Biomed Res Int. 2017;2017:6061042.10.1155/2017/6061042Search in Google Scholar PubMed PubMed Central

[51] Kot AM, Błażejak S, Kieliszek M, Gientka I, Piwowarek K, Brzezińska R. Production of lipids and carotenoids by Rhodotorula gracilis ATCC 10788 yeast in a bioreactor using low-cost wastes. Biocatal Agric Biotechnol. 2020;26:101634.10.1016/j.bcab.2020.101634Search in Google Scholar

[52] Rapoport A, Guzhova I, Bernetti L, Buzzini P, Kieliszek M, Kot AM. Carotenoids and some other pigments from fungi and yeasts. Metabolites. 2021;11(2):1–17.10.3390/metabo11020092Search in Google Scholar PubMed PubMed Central

[53] Lehner S, Boles E. Development of vitamin B12 dependency in Saccharomyces cerevisiae. FEMS Yeast Res. 2023;23:foad020.10.1093/femsyr/foad020Search in Google Scholar PubMed

[54] Wang S, Zhan C, Nie S, Tian D, Lu J, Wen M, et al. Enzyme and metabolic engineering strategies for biosynthesis of α-farnesene in Saccharomyces cerevisiae. J Agric Food Chem. 2023;71(33):12452–61.10.1021/acs.jafc.3c03677Search in Google Scholar PubMed

[55] Steyn A, Viljoen-Bloom M, Van VWH. Constructing recombinant Saccharomyces cerevisiae strains for malic-to-fumaric acid conversion. FEMS Microbiol Lett. 2023;370:1–9.10.1093/femsle/fnad003Search in Google Scholar PubMed PubMed Central

[56] Zhou P, Zhou X, Yuan D, Fang X, Pang X, Yuan KY, et al. Combining protein and organelle engineering for linalool overproduction in saccharomyces cerevisiae. J Agric Food Chem. 2023;71(26):10133–43.10.1021/acs.jafc.2c08416Search in Google Scholar PubMed

[57] Zhao Y, Zuo F, Shu Q, Yang X, Deng Y. Efficient production of glucaric acid by engineered saccharomyces cerevisiae. Appl Environ Microbiol. 2023;89(6):e0053523.10.1128/aem.00535-23Search in Google Scholar PubMed PubMed Central

[58] Zhang Q, Wang X, Zeng W, Xu S, Li D, Yu S. De novo biosynthesis of carminic acid in Saccharomyces cerevisiae. Metab Eng. 2023;76:50–62.10.1016/j.ymben.2023.01.005Search in Google Scholar PubMed

[59] Kim S, Park BG, Jin H, Lee D, Teoh JY, Kim YJ, et al. Efficient production of natural sunscreens shinorine, porphyra-334, and mycosporine-2-glycine in Saccharomyces cerevisiae. Metab Eng. 2023;78:137–47.10.1016/j.ymben.2023.05.009Search in Google Scholar PubMed

[60] Luo G, Lin Y, Chen S, Xiao R, Zhang J, Li C, et al. Overproduction of Patchoulol in Metabolically Engineered Komagataella phaffii. J Agric Food Chem. 2023;71(4):2049–58.10.1021/acs.jafc.2c08228Search in Google Scholar PubMed

[61] Chen B, Liu X, Wang Y, Bai J, Liu X, Xiang G, et al. Production of the antidepressant orcinol glucoside in Yarrowia lipolytica with yields over 6,400-fold higher than plant extraction. PLoS Biol. 2023;21(6):e3002131.10.1371/journal.pbio.3002131Search in Google Scholar PubMed PubMed Central

[62] Gosalawit C, Khunnonkwao P, Jantama K. Genome engineering of Kluyveromyces marxianus for high D-(-)-lactic acid production under low pH conditions. Appl Microbiol Biotechnol. 2023;107(16):5095–105.10.1007/s00253-023-12658-2Search in Google Scholar PubMed

[63] Su C, Gong JS, Wu ZX, Liu Y, Li H, Shi J, et al. Development of a Growth-Dependent System to Regulate Cell Growth and Keratinase Production in B. subtilis. J Agric Food Chem. 2023;71(5):2421–9.10.1021/acs.jafc.2c07624Search in Google Scholar PubMed

[64] Yin X, Zhou Y, Yang H, Liao Y, Ma T, Wang F, et al. Enhanced selenocysteine biosynthesis for seleno-methylselenocysteine production in Bacillus subtilis. Appl Microbiol Biotechnol. 2023;107(9):2843–54.10.1007/s00253-023-12482-8Search in Google Scholar PubMed

[65] Kieliszek M, Kot AM, Kolotylo V. Bioaccumulation of selenium and production of carotenoids by the yeast Rhodotorula mucilaginosa. Biocatal Agric Biotechnol. 2023;53:102903.10.1016/j.bcab.2023.102903Search in Google Scholar

[66] Kieliszek M, Błazejak S, Kurek E. Binding and Conversion of Selenium in Candida utilis ATCC 9950 Yeasts in Bioreactor Culture. Molecules. 2017;22(3):352.10.3390/molecules22030352Search in Google Scholar PubMed PubMed Central

[67] Kieliszek M, Bierla K, Jiménez-Lamana J, Kot AM, Alcántara-Durán J, Piwowarek K, et al. Metabolic RESPONSE of the yeast Candida utilis during enrichment in selenium. Int J Mol Sci. 2020;21(15):5287.10.3390/ijms21155287Search in Google Scholar PubMed PubMed Central

[68] Kieliszek M, Błażejak S, Bzducha-Wróbel A, Kot AM. Effect of selenium on lipid and amino acid metabolism in yeast cells. Biol Trace Elem Res. 2019;187(1):316–27.10.1007/s12011-018-1342-xSearch in Google Scholar PubMed PubMed Central

[69] Kieliszek M, Waśko A, Michalak K, Kot AM, Piwowarek K, Winiarczyk S, et al. Effect of selenium and methods of protein extraction on the proteomic profile of Saccharomyces yeast. Open Life Sci. 2022;17(1):1117–28.10.1515/biol-2022-0496Search in Google Scholar PubMed PubMed Central

[70] Jach ME, Serefko A, Ziaja M, Kieliszek M. Yeast protein as an easily accessible food source. Metabolites. 2022;12(1):63.10.3390/metabo12010063Search in Google Scholar PubMed PubMed Central

[71] Bıyıklı A, Niçin R, Dertli E, Şimşek Ö. Extracellular recombinant production of 4,6 and 4,3 α-glucanotransferases in Lactococcus lactis. Enzyme Microb Technol. 2023;164:110175.10.1016/j.enzmictec.2022.110175Search in Google Scholar PubMed

[72] Tao X, Morgan JS, Liu J, Kempher ML, Xu T, Zhou J. Target integration of an exogenous β-glucosidase enhances cellulose degradation and ethanol production in Clostridium cellulolyticum. Bioresour Technol. 2023;376:128849.10.1016/j.biortech.2023.128849Search in Google Scholar PubMed

[73] Wang C, Yang Y, Ma C, Sunkang Y, Tang S, Zhang Z, et al. Expression of β-Glucosidases from the yak rumen in lactic acid bacteria: a genetic engineering approach. Microorganisms. 2023;11(6):1387.10.3390/microorganisms11061387Search in Google Scholar PubMed PubMed Central

[74] Li J, Chen Y, Gao A, Li J, Chen Y, Gao A, et al. Simultaneous production of cellulase and β-carotene in the filamentous fungus Trichoderma reesei. J Agric Food Chem. 2023;71(16):6358–65.10.1021/acs.jafc.3c00690Search in Google Scholar PubMed

[75] Zhu Z, Zhang M, Liu D, Liu D, Sun T, Yang Y, et al. Development of the thermophilic fungus Myceliophthora thermophila into glucoamylase hyperproduction system via the metabolic engineering using improved AsCas12a variants. Microb Cell Fact. 2023;22(1):1–17.10.1186/s12934-023-02149-4Search in Google Scholar PubMed PubMed Central

[76] Yao Y, Yang EL, Pan Y, Shu X, Liu G. Mining an O-methyltransferase for de novo biosynthesis of physcion in Aspergillus nidulans. Appl Microbiol Biotechnol. 2023;107(4):1177–88.10.1007/s00253-023-12373-ySearch in Google Scholar PubMed

[77] Amendola S, Kneip JS, Meyer F, Perozeni F, Cazzaniga S, Lauersen KJ, et al. Metabolic engineering for efficient ketocarotenoid accumulation in the green microalga chlamydomonas reinhardtii. ACS Synth Biol. 2023;12(3):820–31.10.1021/acssynbio.2c00616Search in Google Scholar PubMed

[78] Zhu F, Li G, Wei P, Song C, Xu Q, Ma M, et al. Rational engineering of a metalloprotease to enhance thermostability and activity. Enzyme Microb Technol. 2023;162:110123.10.1016/j.enzmictec.2022.110123Search in Google Scholar PubMed

[79] Zheng N, Gao L, Long M, Zhang Z, Zhu C, Lv X, et al. Isothermal compressibility perturbation as a protein design principle for T1 lipase stability-activity trade-off counteracting. J Agric Food Chem. 2023;71(17):6681–90.10.1021/acs.jafc.3c01684Search in Google Scholar PubMed

[80] Yuan S, Yan R, Lin B, Li R, Ye X. Improving thermostability of Bacillus amyloliquefaciens alpha-amylase by multipoint mutations. Biochem Biophys Res Commun. 2023;653:69–75.10.1016/j.bbrc.2023.02.064Search in Google Scholar PubMed

[81] Sana B, Ding K, Siau JW, Pasula RR, Chee S, Kharel S, et al. Thermostability enhancement of polyethylene terephthalate degrading PETase using self- and nonself-ligating protein scaffolding approaches. Biotechnol Bioeng. 2023;120(11):3200–09.10.1002/bit.28523Search in Google Scholar PubMed

[82] Goris M, Cea-Rama I, Puntervoll P, Ree R, Almendral D, Sanz-Aparicio J, et al. Increased thermostability of an engineered flavin-containing monooxygenase to remediate trimethylamine in fish protein hydrolysates. Appl Environ Microbiol. 2023;89(6):e0039023.10.1128/aem.00390-23Search in Google Scholar PubMed PubMed Central

[83] Hu J, Chen X, Zhang L, Li Z. Engineering the thermostability of a d- carbamoylase based on ancestral sequence reconstruction for the efficient synthesis of d-tryptophan. J Agric Food Chem. 2022;71(1):660–70.10.1021/acs.jafc.2c07781Search in Google Scholar PubMed

[84] Sardiña-Peña AJ, Ballinas-Casarrubias L, Siqueiros-Cendón TS, Espinoza-Sánchez EA, Flores-Holguín RN, Iglesias-Figueroa BF, et al. Thermostability improvement of sucrose isomerase PalI NX-5: a comprehensive strategy. Biotechnol Lett. 2023;45(7):885–904.10.1007/s10529-023-03388-6Search in Google Scholar PubMed

[85] Chi H, Zhu X, Shen J, Lu Z, Lu F, Lyu Y, et al. Thermostability enhancement and insight of L-asparaginase from Mycobacterium sp. via consensus-guided engineering. Appl Microbiol Biotechnol. 2023;107(7–8):2321–33.10.1007/s00253-023-12443-1Search in Google Scholar PubMed

[86] Zhao L, Ma Z, Wang Q, Hu M, Zhang J, Chen L, et al. Engineering the Thermostability of sucrose synthase by reshaping the subunit interaction contributes to efficient UDP-glucose production. J Agric Food Chem. 2023;71(8):3832–41.10.1021/acs.jafc.2c08642Search in Google Scholar PubMed

[87] Xie WJ, Warshel A. Harnessing generative AI to decode enzyme catalysis and evolution for enhanced engineering. Natl Sci Rev. 2023;0(12):nwad331.10.1093/nsr/nwad331Search in Google Scholar PubMed PubMed Central

[88] Yu T, Cui H, Li JC, Jiang G, Zhao H. Enzyme function prediction using contrastive learning. Science. 2023;379(6639):1358–63.10.1126/science.adf2465Search in Google Scholar PubMed

Received: 2023-11-24
Revised: 2024-03-01
Accepted: 2024-03-13
Published Online: 2024-06-17

© 2024 the author(s), published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Biomedical Sciences
  2. Constitutive and evoked release of ATP in adult mouse olfactory epithelium
  3. LARP1 knockdown inhibits cultured gastric carcinoma cell cycle progression and metastatic behavior
  4. PEGylated porcine–human recombinant uricase: A novel fusion protein with improved efficacy and safety for the treatment of hyperuricemia and renal complications
  5. Research progress on ocular complications caused by type 2 diabetes mellitus and the function of tears and blepharons
  6. The role and mechanism of esketamine in preventing and treating remifentanil-induced hyperalgesia based on the NMDA receptor–CaMKII pathway
  7. Brucella infection combined with Nocardia infection: A case report and literature review
  8. Detection of serum interleukin-18 level and neutrophil/lymphocyte ratio in patients with antineutrophil cytoplasmic antibody-associated vasculitis and its clinical significance
  9. Ang-1, Ang-2, and Tie2 are diagnostic biomarkers for Henoch-Schönlein purpura and pediatric-onset systemic lupus erythematous
  10. PTTG1 induces pancreatic cancer cell proliferation and promotes aerobic glycolysis by regulating c-myc
  11. Role of serum B-cell-activating factor and interleukin-17 as biomarkers in the classification of interstitial pneumonia with autoimmune features
  12. Effectiveness and safety of a mumps containing vaccine in preventing laboratory-confirmed mumps cases from 2002 to 2017: A meta-analysis
  13. Low levels of sex hormone-binding globulin predict an increased breast cancer risk and its underlying molecular mechanisms
  14. A case of Trousseau syndrome: Screening, detection and complication
  15. Application of the integrated airway humidification device enhances the humidification effect of the rabbit tracheotomy model
  16. Preparation of Cu2+/TA/HAP composite coating with anti-bacterial and osteogenic potential on 3D-printed porous Ti alloy scaffolds for orthopedic applications
  17. Aquaporin-8 promotes human dermal fibroblasts to counteract hydrogen peroxide-induced oxidative damage: A novel target for management of skin aging
  18. Current research and evidence gaps on placental development in iron deficiency anemia
  19. Single-nucleotide polymorphism rs2910829 in PDE4D is related to stroke susceptibility in Chinese populations: The results of a meta-analysis
  20. Pheochromocytoma-induced myocardial infarction: A case report
  21. Kaempferol regulates apoptosis and migration of neural stem cells to attenuate cerebral infarction by O‐GlcNAcylation of β-catenin
  22. Sirtuin 5 regulates acute myeloid leukemia cell viability and apoptosis by succinylation modification of glycine decarboxylase
  23. Apigenin 7-glucoside impedes hypoxia-induced malignant phenotypes of cervical cancer cells in a p16-dependent manner
  24. KAT2A changes the function of endometrial stromal cells via regulating the succinylation of ENO1
  25. Current state of research on copper complexes in the treatment of breast cancer
  26. Exploring antioxidant strategies in the pathogenesis of ALS
  27. Helicobacter pylori causes gastric dysbacteriosis in chronic gastritis patients
  28. IL-33/soluble ST2 axis is associated with radiation-induced cardiac injury
  29. The predictive value of serum NLR, SII, and OPNI for lymph node metastasis in breast cancer patients with internal mammary lymph nodes after thoracoscopic surgery
  30. Carrying SNP rs17506395 (T > G) in TP63 gene and CCR5Δ32 mutation associated with the occurrence of breast cancer in Burkina Faso
  31. P2X7 receptor: A receptor closely linked with sepsis-associated encephalopathy
  32. Probiotics for inflammatory bowel disease: Is there sufficient evidence?
  33. Identification of KDM4C as a gene conferring drug resistance in multiple myeloma
  34. Microbial perspective on the skin–gut axis and atopic dermatitis
  35. Thymosin α1 combined with XELOX improves immune function and reduces serum tumor markers in colorectal cancer patients after radical surgery
  36. Highly specific vaginal microbiome signature for gynecological cancers
  37. Sample size estimation for AQP4-IgG seropositive optic neuritis: Retinal damage detection by optical coherence tomography
  38. The effects of SDF-1 combined application with VEGF on femoral distraction osteogenesis in rats
  39. Fabrication and characterization of gold nanoparticles using alginate: In vitro and in vivo assessment of its administration effects with swimming exercise on diabetic rats
  40. Mitigating digestive disorders: Action mechanisms of Mediterranean herbal active compounds
  41. Distribution of CYP2D6 and CYP2C19 gene polymorphisms in Han and Uygur populations with breast cancer in Xinjiang, China
  42. VSP-2 attenuates secretion of inflammatory cytokines induced by LPS in BV2 cells by mediating the PPARγ/NF-κB signaling pathway
  43. Factors influencing spontaneous hypothermia after emergency trauma and the construction of a predictive model
  44. Long-term administration of morphine specifically alters the level of protein expression in different brain regions and affects the redox state
  45. Application of metagenomic next-generation sequencing technology in the etiological diagnosis of peritoneal dialysis-associated peritonitis
  46. Clinical diagnosis, prevention, and treatment of neurodyspepsia syndrome using intelligent medicine
  47. Case report: Successful bronchoscopic interventional treatment of endobronchial leiomyomas
  48. Preliminary investigation into the genetic etiology of short stature in children through whole exon sequencing of the core family
  49. Cystic adenomyoma of the uterus: Case report and literature review
  50. Mesoporous silica nanoparticles as a drug delivery mechanism
  51. Dynamic changes in autophagy activity in different degrees of pulmonary fibrosis in mice
  52. Vitamin D deficiency and inflammatory markers in type 2 diabetes: Big data insights
  53. Lactate-induced IGF1R protein lactylation promotes proliferation and metabolic reprogramming of lung cancer cells
  54. Meta-analysis on the efficacy of allogeneic hematopoietic stem cell transplantation to treat malignant lymphoma
  55. Mitochondrial DNA drives neuroinflammation through the cGAS-IFN signaling pathway in the spinal cord of neuropathic pain mice
  56. Application value of artificial intelligence algorithm-based magnetic resonance multi-sequence imaging in staging diagnosis of cervical cancer
  57. Embedded monitoring system and teaching of artificial intelligence online drug component recognition
  58. Investigation into the association of FNDC1 and ADAMTS12 gene expression with plumage coloration in Muscovy ducks
  59. Yak meat content in feed and its impact on the growth of rats
  60. A rare case of Richter transformation with breast involvement: A case report and literature review
  61. First report of Nocardia wallacei infection in an immunocompetent patient in Zhejiang province
  62. Rhodococcus equi and Brucella pulmonary mass in immunocompetent: A case report and literature review
  63. Downregulation of RIP3 ameliorates the left ventricular mechanics and function after myocardial infarction via modulating NF-κB/NLRP3 pathway
  64. Evaluation of the role of some non-enzymatic antioxidants among Iraqi patients with non-alcoholic fatty liver disease
  65. The role of Phafin proteins in cell signaling pathways and diseases
  66. Ten-year anemia as initial manifestation of Castleman disease in the abdominal cavity: A case report
  67. Coexistence of hereditary spherocytosis with SPTB P.Trp1150 gene variant and Gilbert syndrome: A case report and literature review
  68. Utilization of convolutional neural networks to analyze microscopic images for high-throughput screening of mesenchymal stem cells
  69. Exploratory evaluation supported by experimental and modeling approaches of Inula viscosa root extract as a potent corrosion inhibitor for mild steel in a 1 M HCl solution
  70. Imaging manifestations of ductal adenoma of the breast: A case report
  71. Gut microbiota and sleep: Interaction mechanisms and therapeutic prospects
  72. Isomangiferin promotes the migration and osteogenic differentiation of rat bone marrow mesenchymal stem cells
  73. Prognostic value and microenvironmental crosstalk of exosome-related signatures in human epidermal growth factor receptor 2 positive breast cancer
  74. Circular RNAs as potential biomarkers for male severe sepsis
  75. Knockdown of Stanniocalcin-1 inhibits growth and glycolysis in oral squamous cell carcinoma cells
  76. The expression and biological role of complement C1s in esophageal squamous cell carcinoma
  77. A novel GNAS mutation in pseudohypoparathyroidism type 1a with articular flexion deformity: A case report
  78. Predictive value of serum magnesium levels for prognosis in patients with non-small cell lung cancer undergoing EGFR-TKI therapy
  79. HSPB1 alleviates acute-on-chronic liver failure via the P53/Bax pathway
  80. IgG4-related disease complicated by PLA2R-associated membranous nephropathy: A case report
  81. Baculovirus-mediated endostatin and angiostatin activation of autophagy through the AMPK/AKT/mTOR pathway inhibits angiogenesis in hepatocellular carcinoma
  82. Metformin mitigates osteoarthritis progression by modulating the PI3K/AKT/mTOR signaling pathway and enhancing chondrocyte autophagy
  83. Evaluation of the activity of antimicrobial peptides against bacterial vaginosis
  84. Atypical presentation of γ/δ mycosis fungoides with an unusual phenotype and SOCS1 mutation
  85. Analysis of the microecological mechanism of diabetic kidney disease based on the theory of “gut–kidney axis”: A systematic review
  86. Omega-3 fatty acids prevent gestational diabetes mellitus via modulation of lipid metabolism
  87. Refractory hypertension complicated with Turner syndrome: A case report
  88. Interaction of ncRNAs and the PI3K/AKT/mTOR pathway: Implications for osteosarcoma
  89. Association of low attenuation area scores with pulmonary function and clinical prognosis in patients with chronic obstructive pulmonary disease
  90. Long non-coding RNAs in bone formation: Key regulators and therapeutic prospects
  91. The deubiquitinating enzyme USP35 regulates the stability of NRF2 protein
  92. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as potential diagnostic markers for rebleeding in patients with esophagogastric variceal bleeding
  93. G protein-coupled receptor 1 participating in the mechanism of mediating gestational diabetes mellitus by phosphorylating the AKT pathway
  94. LL37-mtDNA regulates viability, apoptosis, inflammation, and autophagy in lipopolysaccharide-treated RLE-6TN cells by targeting Hsp90aa1
  95. The analgesic effect of paeoniflorin: A focused review
  96. Chemical composition’s effect on Solanum nigrum Linn.’s antioxidant capacity and erythrocyte protection: Bioactive components and molecular docking analysis
  97. Knockdown of HCK promotes HREC cell viability and inner blood–retinal barrier integrity by regulating the AMPK signaling pathway
  98. The role of rapamycin in the PINK1/Parkin signaling pathway in mitophagy in podocytes
  99. Laryngeal non-Hodgkin lymphoma: Report of four cases and review of the literature
  100. Clinical value of macrogenome next-generation sequencing on infections
  101. Overview of dendritic cells and related pathways in autoimmune uveitis
  102. TAK-242 alleviates diabetic cardiomyopathy via inhibiting pyroptosis and TLR4/CaMKII/NLRP3 pathway
  103. Hypomethylation in promoters of PGC-1α involved in exercise-driven skeletal muscular alterations in old age
  104. Profile and antimicrobial susceptibility patterns of bacteria isolated from effluents of Kolladiba and Debark hospitals
  105. The expression and clinical significance of syncytin-1 in serum exosomes of hepatocellular carcinoma patients
  106. A histomorphometric study to evaluate the therapeutic effects of biosynthesized silver nanoparticles on the kidneys infected with Plasmodium chabaudi
  107. PGRMC1 and PAQR4 are promising molecular targets for a rare subtype of ovarian cancer
  108. Analysis of MDA, SOD, TAOC, MNCV, SNCV, and TSS scores in patients with diabetes peripheral neuropathy
  109. SLIT3 deficiency promotes non-small cell lung cancer progression by modulating UBE2C/WNT signaling
  110. The relationship between TMCO1 and CALR in the pathological characteristics of prostate cancer and its effect on the metastasis of prostate cancer cells
  111. Heterogeneous nuclear ribonucleoprotein K is a potential target for enhancing the chemosensitivity of nasopharyngeal carcinoma
  112. PHB2 alleviates retinal pigment epithelium cell fibrosis by suppressing the AGE–RAGE pathway
  113. Anti-γ-aminobutyric acid-B receptor autoimmune encephalitis with syncope as the initial symptom: Case report and literature review
  114. Comparative analysis of chloroplast genome of Lonicera japonica cv. Damaohua
  115. Human umbilical cord mesenchymal stem cells regulate glutathione metabolism depending on the ERK–Nrf2–HO-1 signal pathway to repair phosphoramide mustard-induced ovarian cancer cells
  116. Electroacupuncture on GB acupoints improves osteoporosis via the estradiol–PI3K–Akt signaling pathway
  117. Renalase protects against podocyte injury by inhibiting oxidative stress and apoptosis in diabetic nephropathy
  118. Review: Dicranostigma leptopodum: A peculiar plant of Papaveraceae
  119. Combination effect of flavonoids attenuates lung cancer cell proliferation by inhibiting the STAT3 and FAK signaling pathway
  120. Renal microangiopathy and immune complex glomerulonephritis induced by anti-tumour agents: A case report
  121. Correlation analysis of AVPR1a and AVPR2 with abnormal water and sodium and potassium metabolism in rats
  122. Gastrointestinal health anti-diarrheal mixture relieves spleen deficiency-induced diarrhea through regulating gut microbiota
  123. Myriad factors and pathways influencing tumor radiotherapy resistance
  124. Exploring the effects of culture conditions on Yapsin (YPS) gene expression in Nakaseomyces glabratus
  125. Screening of prognostic core genes based on cell–cell interaction in the peripheral blood of patients with sepsis
  126. Coagulation factor II thrombin receptor as a promising biomarker in breast cancer management
  127. Ileocecal mucinous carcinoma misdiagnosed as incarcerated hernia: A case report
  128. Methyltransferase like 13 promotes malignant behaviors of bladder cancer cells through targeting PI3K/ATK signaling pathway
  129. The debate between electricity and heat, efficacy and safety of irreversible electroporation and radiofrequency ablation in the treatment of liver cancer: A meta-analysis
  130. ZAG promotes colorectal cancer cell proliferation and epithelial–mesenchymal transition by promoting lipid synthesis
  131. Baicalein inhibits NLRP3 inflammasome activation and mitigates placental inflammation and oxidative stress in gestational diabetes mellitus
  132. Impact of SWCNT-conjugated senna leaf extract on breast cancer cells: A potential apoptotic therapeutic strategy
  133. MFAP5 inhibits the malignant progression of endometrial cancer cells in vitro
  134. Major ozonated autohemotherapy promoted functional recovery following spinal cord injury in adult rats via the inhibition of oxidative stress and inflammation
  135. Axodendritic targeting of TAU and MAP2 and microtubule polarization in iPSC-derived versus SH-SY5Y-derived human neurons
  136. Differential expression of phosphoinositide 3-kinase/protein kinase B and Toll-like receptor/nuclear factor kappa B signaling pathways in experimental obesity Wistar rat model
  137. The therapeutic potential of targeting Oncostatin M and the interleukin-6 family in retinal diseases: A comprehensive review
  138. BA inhibits LPS-stimulated inflammatory response and apoptosis in human middle ear epithelial cells by regulating the Nf-Kb/Iκbα axis
  139. Role of circRMRP and circRPL27 in chronic obstructive pulmonary disease
  140. Investigating the role of hyperexpressed HCN1 in inducing myocardial infarction through activation of the NF-κB signaling pathway
  141. Characterization of phenolic compounds and evaluation of anti-diabetic potential in Cannabis sativa L. seeds: In vivo, in vitro, and in silico studies
  142. Quantitative immunohistochemistry analysis of breast Ki67 based on artificial intelligence
  143. Ecology and Environmental Science
  144. Screening of different growth conditions of Bacillus subtilis isolated from membrane-less microbial fuel cell toward antimicrobial activity profiling
  145. Degradation of a mixture of 13 polycyclic aromatic hydrocarbons by commercial effective microorganisms
  146. Evaluation of the impact of two citrus plants on the variation of Panonychus citri (Acari: Tetranychidae) and beneficial phytoseiid mites
  147. Prediction of present and future distribution areas of Juniperus drupacea Labill and determination of ethnobotany properties in Antalya Province, Türkiye
  148. Population genetics of Todarodes pacificus (Cephalopoda: Ommastrephidae) in the northwest Pacific Ocean via GBS sequencing
  149. A comparative analysis of dendrometric, macromorphological, and micromorphological characteristics of Pistacia atlantica subsp. atlantica and Pistacia terebinthus in the middle Atlas region of Morocco
  150. Macrofungal sporocarp community in the lichen Scots pine forests
  151. Assessing the proximate compositions of indigenous forage species in Yemen’s pastoral rangelands
  152. Food Science
  153. Gut microbiota changes associated with low-carbohydrate diet intervention for obesity
  154. Reexamination of Aspergillus cristatus phylogeny in dark tea: Characteristics of the mitochondrial genome
  155. Differences in the flavonoid composition of the leaves, fruits, and branches of mulberry are distinguished based on a plant metabolomics approach
  156. Investigating the impact of wet rendering (solventless method) on PUFA-rich oil from catfish (Clarias magur) viscera
  157. Non-linear associations between cardiovascular metabolic indices and metabolic-associated fatty liver disease: A cross-sectional study in the US population (2017–2020)
  158. Knockdown of USP7 alleviates atherosclerosis in ApoE-deficient mice by regulating EZH2 expression
  159. Utility of dairy microbiome as a tool for authentication and traceability
  160. Agriculture
  161. Enhancing faba bean (Vicia faba L.) productivity through establishing the area-specific fertilizer rate recommendation in southwest Ethiopia
  162. Impact of novel herbicide based on synthetic auxins and ALS inhibitor on weed control
  163. Perspectives of pteridophytes microbiome for bioremediation in agricultural applications
  164. Fertilizer application parameters for drip-irrigated peanut based on the fertilizer effect function established from a “3414” field trial
  165. Improving the productivity and profitability of maize (Zea mays L.) using optimum blended inorganic fertilization
  166. Application of leaf multispectral analyzer in comparison to hyperspectral device to assess the diversity of spectral reflectance indices in wheat genotypes
  167. Animal Sciences
  168. Knockdown of ANP32E inhibits colorectal cancer cell growth and glycolysis by regulating the AKT/mTOR pathway
  169. Development of a detection chip for major pathogenic drug-resistant genes and drug targets in bovine respiratory system diseases
  170. Exploration of the genetic influence of MYOT and MB genes on the plumage coloration of Muscovy ducks
  171. Transcriptome analysis of adipose tissue in grazing cattle: Identifying key regulators of fat metabolism
  172. Comparison of nutritional value of the wild and cultivated spiny loaches at three growth stages
  173. Transcriptomic analysis of liver immune response in Chinese spiny frog (Quasipaa spinosa) infected with Proteus mirabilis
  174. Disruption of BCAA degradation is a critical characteristic of diabetic cardiomyopathy revealed by integrated transcriptome and metabolome analysis
  175. Plant Sciences
  176. Effect of long-term in-row branch covering on soil microorganisms in pear orchards
  177. Photosynthetic physiological characteristics, growth performance, and element concentrations reveal the calcicole–calcifuge behaviors of three Camellia species
  178. Transcriptome analysis reveals the mechanism of NaHCO3 promoting tobacco leaf maturation
  179. Bioinformatics, expression analysis, and functional verification of allene oxide synthase gene HvnAOS1 and HvnAOS2 in qingke
  180. Water, nitrogen, and phosphorus coupling improves gray jujube fruit quality and yield
  181. Improving grape fruit quality through soil conditioner: Insights from RNA-seq analysis of Cabernet Sauvignon roots
  182. Role of Embinin in the reabsorption of nucleus pulposus in lumbar disc herniation: Promotion of nucleus pulposus neovascularization and apoptosis of nucleus pulposus cells
  183. Revealing the effects of amino acid, organic acid, and phytohormones on the germination of tomato seeds under salinity stress
  184. Combined effects of nitrogen fertilizer and biochar on the growth, yield, and quality of pepper
  185. Comprehensive phytochemical and toxicological analysis of Chenopodium ambrosioides (L.) fractions
  186. Impact of “3414” fertilization on the yield and quality of greenhouse tomatoes
  187. Exploring the coupling mode of water and fertilizer for improving growth, fruit quality, and yield of the pear in the arid region
  188. Metagenomic analysis of endophytic bacteria in seed potato (Solanum tuberosum)
  189. Antibacterial, antifungal, and phytochemical properties of Salsola kali ethanolic extract
  190. Exploring the hepatoprotective properties of citronellol: In vitro and in silico studies on ethanol-induced damage in HepG2 cells
  191. Enhanced osmotic dehydration of watermelon rind using honey–sucrose solutions: A study on pre-treatment efficacy and mass transfer kinetics
  192. Effects of exogenous 2,4-epibrassinolide on photosynthetic traits of 53 cowpea varieties under NaCl stress
  193. Comparative transcriptome analysis of maize (Zea mays L.) seedlings in response to copper stress
  194. An optimization method for measuring the stomata in cassava (Manihot esculenta Crantz) under multiple abiotic stresses
  195. Fosinopril inhibits Ang II-induced VSMC proliferation, phenotype transformation, migration, and oxidative stress through the TGF-β1/Smad signaling pathway
  196. Antioxidant and antimicrobial activities of Salsola imbricata methanolic extract and its phytochemical characterization
  197. Bioengineering and Biotechnology
  198. Absorbable calcium and phosphorus bioactive membranes promote bone marrow mesenchymal stem cells osteogenic differentiation for bone regeneration
  199. New advances in protein engineering for industrial applications: Key takeaways
  200. An overview of the production and use of Bacillus thuringiensis toxin
  201. Research progress of nanoparticles in diagnosis and treatment of hepatocellular carcinoma
  202. Bioelectrochemical biosensors for water quality assessment and wastewater monitoring
  203. PEI/MMNs@LNA-542 nanoparticles alleviate ICU-acquired weakness through targeted autophagy inhibition and mitochondrial protection
  204. Unleashing of cytotoxic effects of thymoquinone-bovine serum albumin nanoparticles on A549 lung cancer cells
  205. Erratum
  206. Erratum to “Investigating the association between dietary patterns and glycemic control among children and adolescents with T1DM”
  207. Erratum to “Activation of hypermethylated P2RY1 mitigates gastric cancer by promoting apoptosis and inhibiting proliferation”
  208. Retraction
  209. Retraction to “MiR-223-3p regulates cell viability, migration, invasion, and apoptosis of non-small cell lung cancer cells by targeting RHOB”
  210. Retraction to “A data mining technique for detecting malignant mesothelioma cancer using multiple regression analysis”
  211. Special Issue on Advances in Neurodegenerative Disease Research and Treatment
  212. Transplantation of human neural stem cell prevents symptomatic motor behavior disability in a rat model of Parkinson’s disease
  213. Special Issue on Multi-omics
  214. Inflammasome complex genes with clinical relevance suggest potential as therapeutic targets for anti-tumor drugs in clear cell renal cell carcinoma
  215. Gastroesophageal varices in primary biliary cholangitis with anti-centromere antibody positivity: Early onset?
https://doi.org/10.1515/biol-2022-0856
Keywords for this article
protein and enzyme engineering; industrial biotechnology; thermostability; Escherichia coli; Saccharomyces cerevisiae; yeast; bacteria; fungi; algae
Creative Commons
BY 4.0

Articles in the same Issue

  1. Biomedical Sciences
  2. Constitutive and evoked release of ATP in adult mouse olfactory epithelium
  3. LARP1 knockdown inhibits cultured gastric carcinoma cell cycle progression and metastatic behavior
  4. PEGylated porcine–human recombinant uricase: A novel fusion protein with improved efficacy and safety for the treatment of hyperuricemia and renal complications
  5. Research progress on ocular complications caused by type 2 diabetes mellitus and the function of tears and blepharons
  6. The role and mechanism of esketamine in preventing and treating remifentanil-induced hyperalgesia based on the NMDA receptor–CaMKII pathway
  7. Brucella infection combined with Nocardia infection: A case report and literature review
  8. Detection of serum interleukin-18 level and neutrophil/lymphocyte ratio in patients with antineutrophil cytoplasmic antibody-associated vasculitis and its clinical significance
  9. Ang-1, Ang-2, and Tie2 are diagnostic biomarkers for Henoch-Schönlein purpura and pediatric-onset systemic lupus erythematous
  10. PTTG1 induces pancreatic cancer cell proliferation and promotes aerobic glycolysis by regulating c-myc
  11. Role of serum B-cell-activating factor and interleukin-17 as biomarkers in the classification of interstitial pneumonia with autoimmune features
  12. Effectiveness and safety of a mumps containing vaccine in preventing laboratory-confirmed mumps cases from 2002 to 2017: A meta-analysis
  13. Low levels of sex hormone-binding globulin predict an increased breast cancer risk and its underlying molecular mechanisms
  14. A case of Trousseau syndrome: Screening, detection and complication
  15. Application of the integrated airway humidification device enhances the humidification effect of the rabbit tracheotomy model
  16. Preparation of Cu2+/TA/HAP composite coating with anti-bacterial and osteogenic potential on 3D-printed porous Ti alloy scaffolds for orthopedic applications
  17. Aquaporin-8 promotes human dermal fibroblasts to counteract hydrogen peroxide-induced oxidative damage: A novel target for management of skin aging
  18. Current research and evidence gaps on placental development in iron deficiency anemia
  19. Single-nucleotide polymorphism rs2910829 in PDE4D is related to stroke susceptibility in Chinese populations: The results of a meta-analysis
  20. Pheochromocytoma-induced myocardial infarction: A case report
  21. Kaempferol regulates apoptosis and migration of neural stem cells to attenuate cerebral infarction by O‐GlcNAcylation of β-catenin
  22. Sirtuin 5 regulates acute myeloid leukemia cell viability and apoptosis by succinylation modification of glycine decarboxylase
  23. Apigenin 7-glucoside impedes hypoxia-induced malignant phenotypes of cervical cancer cells in a p16-dependent manner
  24. KAT2A changes the function of endometrial stromal cells via regulating the succinylation of ENO1
  25. Current state of research on copper complexes in the treatment of breast cancer
  26. Exploring antioxidant strategies in the pathogenesis of ALS
  27. Helicobacter pylori causes gastric dysbacteriosis in chronic gastritis patients
  28. IL-33/soluble ST2 axis is associated with radiation-induced cardiac injury
  29. The predictive value of serum NLR, SII, and OPNI for lymph node metastasis in breast cancer patients with internal mammary lymph nodes after thoracoscopic surgery
  30. Carrying SNP rs17506395 (T > G) in TP63 gene and CCR5Δ32 mutation associated with the occurrence of breast cancer in Burkina Faso
  31. P2X7 receptor: A receptor closely linked with sepsis-associated encephalopathy
  32. Probiotics for inflammatory bowel disease: Is there sufficient evidence?
  33. Identification of KDM4C as a gene conferring drug resistance in multiple myeloma
  34. Microbial perspective on the skin–gut axis and atopic dermatitis
  35. Thymosin α1 combined with XELOX improves immune function and reduces serum tumor markers in colorectal cancer patients after radical surgery
  36. Highly specific vaginal microbiome signature for gynecological cancers
  37. Sample size estimation for AQP4-IgG seropositive optic neuritis: Retinal damage detection by optical coherence tomography
  38. The effects of SDF-1 combined application with VEGF on femoral distraction osteogenesis in rats
  39. Fabrication and characterization of gold nanoparticles using alginate: In vitro and in vivo assessment of its administration effects with swimming exercise on diabetic rats
  40. Mitigating digestive disorders: Action mechanisms of Mediterranean herbal active compounds
  41. Distribution of CYP2D6 and CYP2C19 gene polymorphisms in Han and Uygur populations with breast cancer in Xinjiang, China
  42. VSP-2 attenuates secretion of inflammatory cytokines induced by LPS in BV2 cells by mediating the PPARγ/NF-κB signaling pathway
  43. Factors influencing spontaneous hypothermia after emergency trauma and the construction of a predictive model
  44. Long-term administration of morphine specifically alters the level of protein expression in different brain regions and affects the redox state
  45. Application of metagenomic next-generation sequencing technology in the etiological diagnosis of peritoneal dialysis-associated peritonitis
  46. Clinical diagnosis, prevention, and treatment of neurodyspepsia syndrome using intelligent medicine
  47. Case report: Successful bronchoscopic interventional treatment of endobronchial leiomyomas
  48. Preliminary investigation into the genetic etiology of short stature in children through whole exon sequencing of the core family
  49. Cystic adenomyoma of the uterus: Case report and literature review
  50. Mesoporous silica nanoparticles as a drug delivery mechanism
  51. Dynamic changes in autophagy activity in different degrees of pulmonary fibrosis in mice
  52. Vitamin D deficiency and inflammatory markers in type 2 diabetes: Big data insights
  53. Lactate-induced IGF1R protein lactylation promotes proliferation and metabolic reprogramming of lung cancer cells
  54. Meta-analysis on the efficacy of allogeneic hematopoietic stem cell transplantation to treat malignant lymphoma
  55. Mitochondrial DNA drives neuroinflammation through the cGAS-IFN signaling pathway in the spinal cord of neuropathic pain mice
  56. Application value of artificial intelligence algorithm-based magnetic resonance multi-sequence imaging in staging diagnosis of cervical cancer
  57. Embedded monitoring system and teaching of artificial intelligence online drug component recognition
  58. Investigation into the association of FNDC1 and ADAMTS12 gene expression with plumage coloration in Muscovy ducks
  59. Yak meat content in feed and its impact on the growth of rats
  60. A rare case of Richter transformation with breast involvement: A case report and literature review
  61. First report of Nocardia wallacei infection in an immunocompetent patient in Zhejiang province
  62. Rhodococcus equi and Brucella pulmonary mass in immunocompetent: A case report and literature review
  63. Downregulation of RIP3 ameliorates the left ventricular mechanics and function after myocardial infarction via modulating NF-κB/NLRP3 pathway
  64. Evaluation of the role of some non-enzymatic antioxidants among Iraqi patients with non-alcoholic fatty liver disease
  65. The role of Phafin proteins in cell signaling pathways and diseases
  66. Ten-year anemia as initial manifestation of Castleman disease in the abdominal cavity: A case report
  67. Coexistence of hereditary spherocytosis with SPTB P.Trp1150 gene variant and Gilbert syndrome: A case report and literature review
  68. Utilization of convolutional neural networks to analyze microscopic images for high-throughput screening of mesenchymal stem cells
  69. Exploratory evaluation supported by experimental and modeling approaches of Inula viscosa root extract as a potent corrosion inhibitor for mild steel in a 1 M HCl solution
  70. Imaging manifestations of ductal adenoma of the breast: A case report
  71. Gut microbiota and sleep: Interaction mechanisms and therapeutic prospects
  72. Isomangiferin promotes the migration and osteogenic differentiation of rat bone marrow mesenchymal stem cells
  73. Prognostic value and microenvironmental crosstalk of exosome-related signatures in human epidermal growth factor receptor 2 positive breast cancer
  74. Circular RNAs as potential biomarkers for male severe sepsis
  75. Knockdown of Stanniocalcin-1 inhibits growth and glycolysis in oral squamous cell carcinoma cells
  76. The expression and biological role of complement C1s in esophageal squamous cell carcinoma
  77. A novel GNAS mutation in pseudohypoparathyroidism type 1a with articular flexion deformity: A case report
  78. Predictive value of serum magnesium levels for prognosis in patients with non-small cell lung cancer undergoing EGFR-TKI therapy
  79. HSPB1 alleviates acute-on-chronic liver failure via the P53/Bax pathway
  80. IgG4-related disease complicated by PLA2R-associated membranous nephropathy: A case report
  81. Baculovirus-mediated endostatin and angiostatin activation of autophagy through the AMPK/AKT/mTOR pathway inhibits angiogenesis in hepatocellular carcinoma
  82. Metformin mitigates osteoarthritis progression by modulating the PI3K/AKT/mTOR signaling pathway and enhancing chondrocyte autophagy
  83. Evaluation of the activity of antimicrobial peptides against bacterial vaginosis
  84. Atypical presentation of γ/δ mycosis fungoides with an unusual phenotype and SOCS1 mutation
  85. Analysis of the microecological mechanism of diabetic kidney disease based on the theory of “gut–kidney axis”: A systematic review
  86. Omega-3 fatty acids prevent gestational diabetes mellitus via modulation of lipid metabolism
  87. Refractory hypertension complicated with Turner syndrome: A case report
  88. Interaction of ncRNAs and the PI3K/AKT/mTOR pathway: Implications for osteosarcoma
  89. Association of low attenuation area scores with pulmonary function and clinical prognosis in patients with chronic obstructive pulmonary disease
  90. Long non-coding RNAs in bone formation: Key regulators and therapeutic prospects
  91. The deubiquitinating enzyme USP35 regulates the stability of NRF2 protein
  92. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as potential diagnostic markers for rebleeding in patients with esophagogastric variceal bleeding
  93. G protein-coupled receptor 1 participating in the mechanism of mediating gestational diabetes mellitus by phosphorylating the AKT pathway
  94. LL37-mtDNA regulates viability, apoptosis, inflammation, and autophagy in lipopolysaccharide-treated RLE-6TN cells by targeting Hsp90aa1
  95. The analgesic effect of paeoniflorin: A focused review
  96. Chemical composition’s effect on Solanum nigrum Linn.’s antioxidant capacity and erythrocyte protection: Bioactive components and molecular docking analysis
  97. Knockdown of HCK promotes HREC cell viability and inner blood–retinal barrier integrity by regulating the AMPK signaling pathway
  98. The role of rapamycin in the PINK1/Parkin signaling pathway in mitophagy in podocytes
  99. Laryngeal non-Hodgkin lymphoma: Report of four cases and review of the literature
  100. Clinical value of macrogenome next-generation sequencing on infections
  101. Overview of dendritic cells and related pathways in autoimmune uveitis
  102. TAK-242 alleviates diabetic cardiomyopathy via inhibiting pyroptosis and TLR4/CaMKII/NLRP3 pathway
  103. Hypomethylation in promoters of PGC-1α involved in exercise-driven skeletal muscular alterations in old age
  104. Profile and antimicrobial susceptibility patterns of bacteria isolated from effluents of Kolladiba and Debark hospitals
  105. The expression and clinical significance of syncytin-1 in serum exosomes of hepatocellular carcinoma patients
  106. A histomorphometric study to evaluate the therapeutic effects of biosynthesized silver nanoparticles on the kidneys infected with Plasmodium chabaudi
  107. PGRMC1 and PAQR4 are promising molecular targets for a rare subtype of ovarian cancer
  108. Analysis of MDA, SOD, TAOC, MNCV, SNCV, and TSS scores in patients with diabetes peripheral neuropathy
  109. SLIT3 deficiency promotes non-small cell lung cancer progression by modulating UBE2C/WNT signaling
  110. The relationship between TMCO1 and CALR in the pathological characteristics of prostate cancer and its effect on the metastasis of prostate cancer cells
  111. Heterogeneous nuclear ribonucleoprotein K is a potential target for enhancing the chemosensitivity of nasopharyngeal carcinoma
  112. PHB2 alleviates retinal pigment epithelium cell fibrosis by suppressing the AGE–RAGE pathway
  113. Anti-γ-aminobutyric acid-B receptor autoimmune encephalitis with syncope as the initial symptom: Case report and literature review
  114. Comparative analysis of chloroplast genome of Lonicera japonica cv. Damaohua
  115. Human umbilical cord mesenchymal stem cells regulate glutathione metabolism depending on the ERK–Nrf2–HO-1 signal pathway to repair phosphoramide mustard-induced ovarian cancer cells
  116. Electroacupuncture on GB acupoints improves osteoporosis via the estradiol–PI3K–Akt signaling pathway
  117. Renalase protects against podocyte injury by inhibiting oxidative stress and apoptosis in diabetic nephropathy
  118. Review: Dicranostigma leptopodum: A peculiar plant of Papaveraceae
  119. Combination effect of flavonoids attenuates lung cancer cell proliferation by inhibiting the STAT3 and FAK signaling pathway
  120. Renal microangiopathy and immune complex glomerulonephritis induced by anti-tumour agents: A case report
  121. Correlation analysis of AVPR1a and AVPR2 with abnormal water and sodium and potassium metabolism in rats
  122. Gastrointestinal health anti-diarrheal mixture relieves spleen deficiency-induced diarrhea through regulating gut microbiota
  123. Myriad factors and pathways influencing tumor radiotherapy resistance
  124. Exploring the effects of culture conditions on Yapsin (YPS) gene expression in Nakaseomyces glabratus
  125. Screening of prognostic core genes based on cell–cell interaction in the peripheral blood of patients with sepsis
  126. Coagulation factor II thrombin receptor as a promising biomarker in breast cancer management
  127. Ileocecal mucinous carcinoma misdiagnosed as incarcerated hernia: A case report
  128. Methyltransferase like 13 promotes malignant behaviors of bladder cancer cells through targeting PI3K/ATK signaling pathway
  129. The debate between electricity and heat, efficacy and safety of irreversible electroporation and radiofrequency ablation in the treatment of liver cancer: A meta-analysis
  130. ZAG promotes colorectal cancer cell proliferation and epithelial–mesenchymal transition by promoting lipid synthesis
  131. Baicalein inhibits NLRP3 inflammasome activation and mitigates placental inflammation and oxidative stress in gestational diabetes mellitus
  132. Impact of SWCNT-conjugated senna leaf extract on breast cancer cells: A potential apoptotic therapeutic strategy
  133. MFAP5 inhibits the malignant progression of endometrial cancer cells in vitro
  134. Major ozonated autohemotherapy promoted functional recovery following spinal cord injury in adult rats via the inhibition of oxidative stress and inflammation
  135. Axodendritic targeting of TAU and MAP2 and microtubule polarization in iPSC-derived versus SH-SY5Y-derived human neurons
  136. Differential expression of phosphoinositide 3-kinase/protein kinase B and Toll-like receptor/nuclear factor kappa B signaling pathways in experimental obesity Wistar rat model
  137. The therapeutic potential of targeting Oncostatin M and the interleukin-6 family in retinal diseases: A comprehensive review
  138. BA inhibits LPS-stimulated inflammatory response and apoptosis in human middle ear epithelial cells by regulating the Nf-Kb/Iκbα axis
  139. Role of circRMRP and circRPL27 in chronic obstructive pulmonary disease
  140. Investigating the role of hyperexpressed HCN1 in inducing myocardial infarction through activation of the NF-κB signaling pathway
  141. Characterization of phenolic compounds and evaluation of anti-diabetic potential in Cannabis sativa L. seeds: In vivo, in vitro, and in silico studies
  142. Quantitative immunohistochemistry analysis of breast Ki67 based on artificial intelligence
  143. Ecology and Environmental Science
  144. Screening of different growth conditions of Bacillus subtilis isolated from membrane-less microbial fuel cell toward antimicrobial activity profiling
  145. Degradation of a mixture of 13 polycyclic aromatic hydrocarbons by commercial effective microorganisms
  146. Evaluation of the impact of two citrus plants on the variation of Panonychus citri (Acari: Tetranychidae) and beneficial phytoseiid mites
  147. Prediction of present and future distribution areas of Juniperus drupacea Labill and determination of ethnobotany properties in Antalya Province, Türkiye
  148. Population genetics of Todarodes pacificus (Cephalopoda: Ommastrephidae) in the northwest Pacific Ocean via GBS sequencing
  149. A comparative analysis of dendrometric, macromorphological, and micromorphological characteristics of Pistacia atlantica subsp. atlantica and Pistacia terebinthus in the middle Atlas region of Morocco
  150. Macrofungal sporocarp community in the lichen Scots pine forests
  151. Assessing the proximate compositions of indigenous forage species in Yemen’s pastoral rangelands
  152. Food Science
  153. Gut microbiota changes associated with low-carbohydrate diet intervention for obesity
  154. Reexamination of Aspergillus cristatus phylogeny in dark tea: Characteristics of the mitochondrial genome
  155. Differences in the flavonoid composition of the leaves, fruits, and branches of mulberry are distinguished based on a plant metabolomics approach
  156. Investigating the impact of wet rendering (solventless method) on PUFA-rich oil from catfish (Clarias magur) viscera
  157. Non-linear associations between cardiovascular metabolic indices and metabolic-associated fatty liver disease: A cross-sectional study in the US population (2017–2020)
  158. Knockdown of USP7 alleviates atherosclerosis in ApoE-deficient mice by regulating EZH2 expression
  159. Utility of dairy microbiome as a tool for authentication and traceability
  160. Agriculture
  161. Enhancing faba bean (Vicia faba L.) productivity through establishing the area-specific fertilizer rate recommendation in southwest Ethiopia
  162. Impact of novel herbicide based on synthetic auxins and ALS inhibitor on weed control
  163. Perspectives of pteridophytes microbiome for bioremediation in agricultural applications
  164. Fertilizer application parameters for drip-irrigated peanut based on the fertilizer effect function established from a “3414” field trial
  165. Improving the productivity and profitability of maize (Zea mays L.) using optimum blended inorganic fertilization
  166. Application of leaf multispectral analyzer in comparison to hyperspectral device to assess the diversity of spectral reflectance indices in wheat genotypes
  167. Animal Sciences
  168. Knockdown of ANP32E inhibits colorectal cancer cell growth and glycolysis by regulating the AKT/mTOR pathway
  169. Development of a detection chip for major pathogenic drug-resistant genes and drug targets in bovine respiratory system diseases
  170. Exploration of the genetic influence of MYOT and MB genes on the plumage coloration of Muscovy ducks
  171. Transcriptome analysis of adipose tissue in grazing cattle: Identifying key regulators of fat metabolism
  172. Comparison of nutritional value of the wild and cultivated spiny loaches at three growth stages
  173. Transcriptomic analysis of liver immune response in Chinese spiny frog (Quasipaa spinosa) infected with Proteus mirabilis
  174. Disruption of BCAA degradation is a critical characteristic of diabetic cardiomyopathy revealed by integrated transcriptome and metabolome analysis
  175. Plant Sciences
  176. Effect of long-term in-row branch covering on soil microorganisms in pear orchards
  177. Photosynthetic physiological characteristics, growth performance, and element concentrations reveal the calcicole–calcifuge behaviors of three Camellia species
  178. Transcriptome analysis reveals the mechanism of NaHCO3 promoting tobacco leaf maturation
  179. Bioinformatics, expression analysis, and functional verification of allene oxide synthase gene HvnAOS1 and HvnAOS2 in qingke
  180. Water, nitrogen, and phosphorus coupling improves gray jujube fruit quality and yield
  181. Improving grape fruit quality through soil conditioner: Insights from RNA-seq analysis of Cabernet Sauvignon roots
  182. Role of Embinin in the reabsorption of nucleus pulposus in lumbar disc herniation: Promotion of nucleus pulposus neovascularization and apoptosis of nucleus pulposus cells
  183. Revealing the effects of amino acid, organic acid, and phytohormones on the germination of tomato seeds under salinity stress
  184. Combined effects of nitrogen fertilizer and biochar on the growth, yield, and quality of pepper
  185. Comprehensive phytochemical and toxicological analysis of Chenopodium ambrosioides (L.) fractions
  186. Impact of “3414” fertilization on the yield and quality of greenhouse tomatoes
  187. Exploring the coupling mode of water and fertilizer for improving growth, fruit quality, and yield of the pear in the arid region
  188. Metagenomic analysis of endophytic bacteria in seed potato (Solanum tuberosum)
  189. Antibacterial, antifungal, and phytochemical properties of Salsola kali ethanolic extract
  190. Exploring the hepatoprotective properties of citronellol: In vitro and in silico studies on ethanol-induced damage in HepG2 cells
  191. Enhanced osmotic dehydration of watermelon rind using honey–sucrose solutions: A study on pre-treatment efficacy and mass transfer kinetics
  192. Effects of exogenous 2,4-epibrassinolide on photosynthetic traits of 53 cowpea varieties under NaCl stress
  193. Comparative transcriptome analysis of maize (Zea mays L.) seedlings in response to copper stress
  194. An optimization method for measuring the stomata in cassava (Manihot esculenta Crantz) under multiple abiotic stresses
  195. Fosinopril inhibits Ang II-induced VSMC proliferation, phenotype transformation, migration, and oxidative stress through the TGF-β1/Smad signaling pathway
  196. Antioxidant and antimicrobial activities of Salsola imbricata methanolic extract and its phytochemical characterization
  197. Bioengineering and Biotechnology
  198. Absorbable calcium and phosphorus bioactive membranes promote bone marrow mesenchymal stem cells osteogenic differentiation for bone regeneration
  199. New advances in protein engineering for industrial applications: Key takeaways
  200. An overview of the production and use of Bacillus thuringiensis toxin
  201. Research progress of nanoparticles in diagnosis and treatment of hepatocellular carcinoma
  202. Bioelectrochemical biosensors for water quality assessment and wastewater monitoring
  203. PEI/MMNs@LNA-542 nanoparticles alleviate ICU-acquired weakness through targeted autophagy inhibition and mitochondrial protection
  204. Unleashing of cytotoxic effects of thymoquinone-bovine serum albumin nanoparticles on A549 lung cancer cells
  205. Erratum
  206. Erratum to “Investigating the association between dietary patterns and glycemic control among children and adolescents with T1DM”
  207. Erratum to “Activation of hypermethylated P2RY1 mitigates gastric cancer by promoting apoptosis and inhibiting proliferation”
  208. Retraction
  209. Retraction to “MiR-223-3p regulates cell viability, migration, invasion, and apoptosis of non-small cell lung cancer cells by targeting RHOB”
  210. Retraction to “A data mining technique for detecting malignant mesothelioma cancer using multiple regression analysis”
  211. Special Issue on Advances in Neurodegenerative Disease Research and Treatment
  212. Transplantation of human neural stem cell prevents symptomatic motor behavior disability in a rat model of Parkinson’s disease
  213. Special Issue on Multi-omics
  214. Inflammasome complex genes with clinical relevance suggest potential as therapeutic targets for anti-tumor drugs in clear cell renal cell carcinoma
  215. Gastroesophageal varices in primary biliary cholangitis with anti-centromere antibody positivity: Early onset?
Sign up now to receive a 20% welcome discount
Institutional Access
How does access work?
Have an idea on how to improve our website?
Please write us.
© 2025 De Gruyter Brill
Downloaded on 22.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/biol-2022-0856/html
Scroll to top button